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ABSTRACT 
International non-governmental organizations (INGOs) in the field of sexual and reproductive 
health (SRH) consider access to family planning services a universal human right.  Family 
planning programs should strive to effectively provide information, counseling, and 
contraceptive services to allow women and men the ability to freely determine when and how 
many children they desire to have. 
In developing regions of the world, women are often unable to obtain or use modern 
contraception (mC) for many reasons relating to both supply and demand side factors.  Use of 
mC is lowest in Sub-Saharan Africa (SSA).  Unmet need (i.e., women who desire to delay 
childbearing but are not using any methods to do so) is highest in this region as well.  Higher 
rates of unintended pregnancy are directly related to low mC use and high unmet need.  The 
public health significance of this relationship is great: unintended pregnancy has grave health 
implications for maternal and child morbidity and mortality in the developing world.   
Women of reproductive age in SSA rely primarily on traditional and short-acting 
reversible contraception, which are prone to incorrect or inconsistent usage and failure.  By 
contrast, long-acting reversible contraception (LARC) provides up to ten years of highly 
effective protection against pregnancy.  LARC methods are among the safest, most cost-
effective, and reliable forms of contraception available today.  LARC includes the copper 
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intrauterine device (IUD), levonorgestrel intrauterine system (LNG-IUS), and contraceptive 
implant.  These methods are appropriate for most women, and can be used to space or limit 
childbearing until the user is ready to have children. 
LARC methods have historically been underutilized in SSA, where they could benefit 
millions of women seeking to control their fertility.  Relatively few interventions exist within the 
international development field where LARC has been sustainably introduced into the mC 
method mix in SSA.  This paper reviews and examines the literature on published interventions, 
and provides international development practitioners with useful recommendations for LARC 
promotion in family planning programs moving forward.  These recommendations include 
decentralizing health care networks, building capacity in service delivery and skills training, and 
conducting advocacy and education through social and behavioral change communication 
(SBCC). 
 
 
vi 
TABLE OF CONTENTS 
PREFACE .................................................................................................................................... XI 
1.0 INTRODUCTION................................................................................................................ 1 
2.0 BACKGROUND .................................................................................................................. 4 
2.1 THE BURDEN OF UNINTENDED PREGNANCY ................................................ 4 
2.1.1 Sub-Saharan Africa ......................................................................................... 6 
2.2 THE IMPORTANCE OF FAMILY PLANNING IN DEVELOPMENT ............ 10 
2.2.1 Maternal and Child Health ........................................................................... 11 
2.2.2 Educational Achievement .............................................................................. 12 
2.2.3 Poverty Alleviation ......................................................................................... 12 
2.2.4 Female Empowerment ................................................................................... 13 
2.3 MODERN METHODS OF CONTRACEPTION .................................................. 14 
2.3.1 Short-Acting Reversible Contraception ....................................................... 15 
2.3.1.1 Non-Hormonal Methods .................................................................... 15 
2.3.1.2 Hormonal Methods ............................................................................. 18 
2.3.2 Long-Acting Reversible Contraception ....................................................... 20 
2.3.2.1 Progestin Contraceptive Implant ...................................................... 22 
2.3.2.2 Copper Intrauterine Device (IUD) .................................................... 23 
2.3.2.3 Levonorgestrel-releasing Intrauterine System (LNG-IUS) ............ 24 
  vii 
2.3.3 Permanent Methods ....................................................................................... 25 
3.0 METHODS ......................................................................................................................... 26 
4.0 RESULTS ........................................................................................................................... 28 
4.1 INTERVENTIONS FOR IUD PROVISION .......................................................... 29 
4.1.1 Kenya, National Campaign, 2003–2006 ....................................................... 30 
4.1.2 Guinea, Mandiana District, 2004 .................................................................. 32 
4.1.3 Guinea, Siguiri District, 2004–2006 .............................................................. 34 
4.1.4 Uganda, Four Districts, 2005–2006 .............................................................. 36 
4.1.5 Kenya, Kisii District, 2005–2007 ................................................................... 38 
4.1.6 Ethiopia, Amhara Region, 2005–2007 .......................................................... 40 
4.1.7 Population Services International, Six Countries, 2009–2010 ................... 42 
4.2 INTERVENTIONS FOR IMPLANT PROVISION ............................................... 44 
4.2.1 Ethiopia, Four Regions, 2009–2013 .............................................................. 44 
4.3 INTERVENTIONS FOR IUD AND IMPLANT PROVISION............................. 46 
4.3.1 Zambia, Four Provinces, 2008–2009 ............................................................ 47 
4.3.2 Marie Stopes International, 15 Countries, 2008–2012 ................................ 48 
5.0 DISCUSSION ..................................................................................................................... 51 
5.1 OBSTACLES TO EFFECTIVE LARC PROVISION .......................................... 51 
5.1.1 Supply Side Obstacles .................................................................................... 51 
5.1.1.1 Provider Bias ....................................................................................... 51 
5.1.1.2 Failing Health Infrastructure ............................................................ 52 
5.1.1.3 Weak Political Support ...................................................................... 53 
5.1.1.4 Poor or Nonexistent Funding ............................................................. 53 
  viii 
5.1.1.5 Breaks in the Supply Chain ............................................................... 54 
5.1.2 Demand Side Obstacles ................................................................................. 55 
5.1.2.1 LARC Myths and Misperceptions .................................................... 55 
5.1.2.2 Little Knowledge of LARC ................................................................ 55 
5.1.2.3 Limited Access to Services ................................................................. 56 
5.1.2.4 Social Stigma ....................................................................................... 56 
5.2 EFFECTIVENESS OF LARC INTERVENTIONS ............................................... 57 
5.2.1 Shared Intervention Strengths ...................................................................... 57 
5.2.1.1 Engaging with Community Stakeholders First ................................ 57 
5.2.1.2 Engaging with Client in Local Setting .............................................. 58 
5.2.1.3 Addressing LARC Provision Obstacles ............................................ 60 
5.2.2 Shared Intervention Weaknesses .................................................................. 62 
5.2.2.1 Reliance on Changing Streams of Donor Support........................... 62 
5.2.2.2 Top-Down Program Governance ...................................................... 63 
5.2.2.3 Missing Long-Term Sustainability Plan ........................................... 65 
5.3 OTHER CONSIDERATIONS ................................................................................. 67 
5.3.1 Regional Factors Influencing Client Uptake ............................................... 67 
5.3.2 International Commitment ........................................................................... 70 
5.3.3 Cost-Benefit Analysis ..................................................................................... 72 
6.0 CONCLUSION .................................................................................................................. 75 
6.1 RECOMMENDATIONS FOR FUTURE INTERVENTIONS ............................. 76 
6.1.1 Decentralization of Health Care Networks .................................................. 77 
6.1.2 Capacity Building ........................................................................................... 79 
  ix 
6.1.3 Advocacy and Education ............................................................................... 81 
6.1.4 LARC Champions .......................................................................................... 84 
6.1.5 Community Awareness .................................................................................. 85 
6.2 LIMITATIONS .......................................................................................................... 87 
6.3 PUBLIC HEALTH SIGNIFICANCE ..................................................................... 88 
APPENDIX A : LITERATURE REVIEW ARTICLES ......................................................... 90 
APPENDIX B : TYPES OF LONG-ACTING REVERSIBLE CONTRACEPTION .......... 94 
BIBLIOGRAPHY ....................................................................................................................... 96 
 
 
 
  x 
LIST OF TABLES 
Table 1: Summary of Intervention Outcomes ............................................................................... 29 
Table 2: Summary of Recommendations ...................................................................................... 76 
 
 
  xi 
PREFACE 
This thesis is the result of a lifetime’s worth of support from my family.  I would not be where I 
am today without their unwavering love and encouragement to succeed in my academic pursuits.  
I would also like to thank my boyfriend, Matt, for his needed humor and ability to provide me 
with valuable feedback on my writing, all done while balancing the demands of law school.  You 
have all been so important to my academic success! 
I would also like to extend my gratitude to my thesis committee, for their combined 
efforts and helpful guidance through this semester long process.  I’ve enjoyed our courses 
together through graduate school, and admire each of you as examples of strong, professional 
women whose passion I hope to emulate in my own career path. 
 
 
 
  1 
1.0  INTRODUCTION 
Modern contraception (mC) refers to short-acting, long-acting, and permanent methods of 
contraception that exclude traditional methods.  In 2014, 57 percent of married women in the 
developing world ages 15 to 49 used mC.  Regionally, differences exist with the highest mC rate 
seen in East Asia (88 percent), and the lowest rate continually seen in Sub-Saharan Africa (SSA) 
(19 percent) (Singh, Darroch, & Ashford, 2014; Westoff, 2012).  Unmet need for mC is the 
highest in SSA (Singh et al., 2014).  The public health implications of this are troubling, as low 
patterns of regional mC use can result in higher rates of unintended pregnancy (Singh et al., 
2014).  Unintended pregnancy can produce a range of detrimental effects on health including 
maternal and infant mortality and morbidity (Cleland, Conde-Agudelo, Peterson, Ross, & Tsui, 
2012).  Providing family planning (FP) services can improve these proximal maternal and child 
health (MCH) indicators as well as more distal factors including the education, economic well- 
being, and social empowerment of the women and families who use them (Casterline, 2010). 
 Most women in SSA rely on traditional methods or short-acting reversible contraception, 
such as the oral contraceptive or injectable, to provide desired protection against pregnancy 
(Mbizvo & Phillips, 2014).  These methods are more prone to incorrect or inconsistent usage, 
and subsequent failure resulting in an unintended pregnancy (American Academy of Pediatrics, 
2014).  A skewed mC method mix that favors short-acting methods prevents a woman from 
choosing the best method that suits her unique circumstances and fertility preferences (Sullivan, 
  2 
Bertrand, Rice, & Shelton, 2006).  The skewed mC method mix is in part the result of a variety 
of supply and demand side barriers that prevent women in SSA from obtaining and using their 
preferred mC over their reproductive lifetimes (Jacobstein, Bakamjian, Pile & Wickstrom, 2009). 
 Long-acting reversible contraception, or LARC, has been hailed as one of the most safe 
and effective methods of mC for any woman looking to avoid pregnancy (American College of 
Obstetricians and Gynecologists, 2011).  LARC methods include the copper intrauterine device 
(IUD), levonorgestrel intrauterine system (LNG-IUS) and the contraceptive implant.  Compared 
to their short-acting counterparts, LARC methods are more cost-effective and have lower typical 
and perfect use failure rates over the long-term, meaning that their efficacy in preventing 
pregnancy is among the highest available (Hathaway, Torres, Vollett-Krech, & Wohltjen, 2014).  
While LARC has become more popular among medical providers in the industrialized world, it 
has been slow to gain traction among healthcare systems in SSA (Seiber, Bertrand, & Sullivan, 
2007).  Few health INGOs or national governments have strongly committed to expanding their 
mC method mix to include all forms of LARC, although the benefits of its use are widely known 
among the sexual and reproductive health (SRH) community (Family Planning 2020, 2015b; 
WHO, 2012).  Again, economic, socio-cultural, and sometimes physical barriers prevent women 
in this region of the world from obtaining LARC (Chandra-Mouli, McCarraher, Phillips, 
Williamson, & Hainsworth, 2014; Cleland & Machiyama, 2015). 
 The anticipated benefits of introducing LARC in SSA are compelling enough to warrant 
further research and consideration among international development (ID) practitioners working 
in the SRH field.  With access to LARC, women can delay childbearing for up to ten years with 
minimal user adherence or maintenance beyond routine visits with women’s health providers 
(Espey & Ogburn, 2011).  In a region of the world where women generally stress their desire for 
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contraception to space rather than limit total births, LARC can successfully provide the desired 
window of two years or more between children to better guarantee a healthy child and mom 
(Pile, Ndede, Ndong, Jacobstein, & Johri, 2007). 
The overall objectives of this paper are to (1) examine previously completed family 
planning interventions in SSA that sought to introduce LARC into the mC method mix; (2) 
compare obstacles to LARC provision, in addition to the relative strengths, weaknesses, and 
overall effectiveness of these interventions; and (3) propose a set of recommendations for ID 
practitioners interested in promoting LARC methods among SSA women.  The second chapter 
provides background information for the reader on the burden of unintended pregnancy both 
globally and in SSA.  This chapter examines the importance of family planning in international 
development, and concludes with an overview of modern methods of contraception.  The third 
chapter outlines the methodology for the literature review, including search terms and 
inclusion/exclusion criteria.  The fourth chapter reports on the results of the literature review; 20 
articles met inclusion criteria, and covered ten family planning interventions conducted in 16 
SSA countries.  This chapter provides details on both service delivery and behavioral change 
communication components of each intervention.  The fifth chapter discusses major obstacles to 
LARC provision, overall effectiveness of the interventions, and other considerations.  The final 
sixth chapter concludes with recommendations for future interventions, limitations, and the 
public health significance of LARC promotion in FP programs for SSA.   
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2.0  BACKGROUND 
2.1 THE BURDEN OF UNINTENDED PREGNANCY 
Without access to FP methods to limit fertility, an average woman could have 15 children over 
the course of her lifetime (Cleland, 2009).  Of the estimated 1.6 billion women who are living in 
the developing world and desire to avoid a pregnancy (i.e., either postpone or stop childbearing 
altogether), 26 percent of them are not using any form of modern contraception (Singh et al., 
2014).  More than half of all pregnancies in the world are unplanned; around 80 million 
unintended pregnancies occur annually in the developing world, and it is estimated that 40 
million will result in abortion, 10 million in miscarriage, and 30 million will reach live birth 
(Bongaarts, 2015; WHO, 2012).   
In the developing world, 81 percent of unintended pregnancies are a result of having an 
unmet need for contraception (i.e., either using no contraception or a traditional method) (Singh 
et al., 2014).  Among the causes of unintended pregnancy, 52 percent are attributed to nonuse of 
contraceptive method, while 43 percent are attributed to incorrect or inconsistent use of 
contraceptive method, and just 5 percent to consistent use but method failure (Espey & Ogburn, 
2011).  The Guttmacher Institute estimates an unintended pregnancy rate of 54 per 1,000 in the 
developing world among women ages 15 to 44, compared to 44 per 1,000 in more developed 
regions of the world (Sedgh, Singh, & Hussain, 2014).  The chance of maternal death is much 
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greater in the developing world at one in 51; for women living in Organization for Economic 
Cooperation and Development (OECD) countries, their chance of death from maternal causes is 
just one in 4,000 (Snow, Laski, & Mutumba, 2015). 
Childbirth in early life is especially dangerous.  An estimated 16 million adolescents, 
ages 15 to 19, give birth each year; in the developing world, the leading cause of death among 
adolescent females is complications from pregnancy, birth, and unsafe abortion.  Among women 
25 and younger living in the developing world, maternal sepsis and hemorrhage are common 
causes of death (Krashin, Tang, Mody, & Lopez, 2015).  Adolescent mothers also have infants 
with a 50 percent higher chance of dying in the first week of life than those who are born to 
women older than 20; these infants are also more likely to be born preterm and with a low birth 
weight (Chandra-Mouli et al., 2014; Prata, Weidert, & Sreenivas, 2013).  An estimated 33 
million adolescents worldwide have an unmet need for contraception (Family Planning 2020, 
2015b).   
Human development indicators suggest that a high birth rate within a country can 
compromise the health of both mother and infant through the lifespan (Jacobstein et al., 2009; 
Prata et al., 2013).  Population growth puts ever-increasing pressure on the land to provide 
enough food and space for shelter (Singh et al., 2014).  High population density can be 
conducive to infectious disease transmission and chronic malnutrition among children (Family 
Planning 2020, 2015b; Tsui, McDonald-Mosey, & Burke, 2010).  Large households with many 
children face food insecurity and economic hardship if they are dependent upon one income to 
provide for all (Jacobstein et al., 2009; WHO, 2015a).  Families may have to decide which child 
gets an education and who must work, based on the high price of school uniforms and supplies 
(Prata et al., 2013).  Adolescent women who become pregnant may need to drop out of school 
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and ultimately be unable to complete their education (McCurdy, Schnatz, Weinbaum, & Zhu, 
2014; Singh et al., 2014).  Social services are increasingly overburdened as more people fall into 
extreme poverty (Jacobstein et al., 2009).   
2.1.1 Sub-Saharan Africa 
Fertility rates have declined tremendously over the past few decades in some parts of the world 
including North America, Europe, and more recently Asia and Latin America (Snow et al., 
2015).  Globally, the present total fertility rate (TFR) is 2.5 children per woman; in SSA, the 
regional total fertility rate is 4.5 children per woman (You, Hug, & Anthony, 2015).  In 15 SSA 
countries, the TFR can be up to six children per woman (Jacobstein et al., 2009).  A high fertility 
rate, defined as a total fertility rate of greater than 5.0 births per woman, has not only a large 
impact on the population growth rate of a developing country, but on the lifetime health, 
education, and economic livelihood of the mother and her children as well (Casterline, 2010).   
SSA is experiencing rapid demographic growth as a result of high fertility rates, meaning 
that the total population in this part of the world is expected to double by the year 2050 
(Bongaarts, 2015; You et al., 2015).  That means 1.7 billion people living in the region in 34 
years’ time.  There is immediate concern that with such population growth global efforts to 
reduce poverty and hunger may be stymied, as local food production may not be able to meet 
population demands (Cleland, 2009).  Additionally, the number of women of reproductive age is 
estimated to increase from 280 million in 2015 to 607 million by 2050, which will also result in 
an increasing number of unintended pregnancies and births (You et al., 2015).   
In SSA, an estimated 14 million unintended pregnancies occur each year.  The 
Guttmacher Institute estimates a regional unintended pregnancy rate of 80 per 1,000 women ages 
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15 to 44 (almost double the developed world rate of 44 per 1,000) (Sedgh et al., 2014).  A large 
proportion of these pregnancies is attributed to poor use of short-term hormonal methods, and 
almost half occur among women ages 15 to 24 (Hubacher, Mavranezouli, & McGinn, 2008; 
Williamson, Parkes, Wight, Petticrew, & Hart, 2009).  The annual population growth rate of 2.4 
percent is the highest in the world (Jacobstein et al., 2009).  The proportion of maternal deaths 
worldwide occurring in SSA increased from 23 to 52 percent from 1980 to 2008 (Cleland et al., 
2012).  In SSA, pregnancy is recognized as one of the most dangerous health events in a 
woman’s lifetime.  Women in this region of the world have a one in 22 lifetime risk of maternal 
death (Hubacher et al., 2008; Jacobstein et al., 2009).   
In 2012, roughly 213 million women living in SSA were of reproductive age (15 to 49 
years old).  Of this population, 60 percent of women who reported wanting to avoid pregnancy 
had an unmet need for mC (Darroch & Singh, 2013).  An unmet need refers to the situation of 
women who do not want more children but are not using any methods to prevent pregnancy 
(Cleland & Machiyama, 2015).  Globally, unmet need is highest in SSA (Mbizvo & Phillips, 
2014; Singh et al., 2014).  Three of the top four countries with highest unmet need are located in 
SSA: Liberia, Rwanda, and Uganda (Blumenthal, Voedisch, & Gemzell-Danielsson, 2011).  The 
regional unmet need has declined by only 6.5 percent from 1994 to 2014, compared to an 11.5 
percent decline worldwide (Snow et al., 2015).   
Unmet need in SSA is highest among less-educated, rural, and poor women (Creanga, 
Gillespie, Karklins, & Tsui, 2011; Mbizvo & Phillips, 2014; Singh et al., 2014).  Research also 
suggests it may be higher among ethnic minorities, adolescents, and unmarried women (Doyle, 
Mavedzenge, Plummer, & Ross, 2012; Vernon, Khan, Birungi, Askew, & Stones, 2007).  
Indeed, women in the poorest quintiles, who typically reside in rural areas, tend to have between 
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two to four more children than those in the wealthiest quintile who live in urban areas (You et 
al., 2015).  Additionally, 73 percent of women living in the poorest quintile have an unmet need 
for contraceptives, while 46 percent of the wealthiest quintile report such unmet need (Singh et 
al., 2014).   
The lowest mC prevalence rates have been recorded in West and Central Africa, while 
the highest rates exist in East and Southern Africa (Cleland, 2009; Cleland, Ndugwa, & Zulu, 
2011).  While the global contraceptive prevalence rate is 63 percent, 23 of the 42 countries in the 
region had a contraceptive prevalence rate below 20 percent in 2010 (Cleland & Shah, 2013).  In 
some of the very poorest countries (e.g., Chad and South Sudan), the contraceptive prevalence 
rate is less than 10 percent among married women (Snow et al., 2015).   
SSA has a very large young population.  In fact, 41 of the 42 countries in the region have 
a median age less than or equal to 25 (Prata et al., 2013).  A large proportion of the population 
will soon reach sexual debut and be exposed to the risk of unintended pregnancy as they enter 
their reproductive years (Jacobstein et al., 2009).  Seventy five percent of women report having 
sexual intercourse prior to age 20 (Williamson et al., 2009).  Among sexually active adolescent 
females who are unmarried, mC use is between 20 and 40 percent, and unmet need between 50 
and 65 percent.  Among the same population that is married, mC use ranges from 10 to 35 
percent, while unmet need is generally lower at 15 to 60 percent (Chandra-Mouli et al., 2014).  
The adolescent birth rate is 98 births per 1,000 women, almost double the world average of 50 
(You et al., 2015).  In fact, 44 percent of unintended births in SSA occur among women ages 15 
to 24 (Hubacher et al., 2008).  Unsafe abortions rates are highest among those under the age of 
20, accounting for 57 percent of total unsafe abortions performed in the region (Prata et al., 
2013).   
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Due to shared cultural norms that promote large families, SSA women have expressed 
interest in using mC as a measure more strongly desired for spacing rather than limiting total 
births (Cleland & Machiyama, 2015; Hubacher, Olawo, Manduku, & Kiarie, 2011; Westoff, 
2012).  In 2005 to 2012, among married women ages 15 to 49 in 18 SSA countries, 84 percent of 
mC methods used were short-acting, while just 16 percent were long-acting and permanent 
methods (LAPMs) (Darroch & Singh, 2013).  Among married women, the two most commonly 
used mC methods are injectables (25 percent), which increased by a factor of three from 1984 to 
2005, and the oral contraceptive (19 percent) (Seiber et al., 2007).  Use of the copper IUD and 
LNG-IUS is lowest in SSA; prevalence rates typically range from one to three percent (Vernon 
et al., 2007; Seiber et al., 2007).  One study of adolescents from 18 SSA countries reported a 
strong preference for oral contraceptive pills (31 percent) and injectables (40 percent) among 
current nonusers, with just 0.9 percent interest in the IUD, and 2.4 percent in the implant 
(McCurdy et al., 2014).  Generally, a far greater proportion of women in SSA report knowledge 
of short-acting mC, and overall use of LARC has seen a steady decline since the 1980s when it 
was more popular thanks to national promotional campaigns (Melngailis & Eber, 2006; Seiber et 
al., 2007).   
Reliance on traditional methods (e.g., withdrawal, abstinence) and short-acting mC that 
are more prone to failure from incorrect or inconsistent use means that the risk of unintended 
pregnancy for women in SSA is high (Family Health International, 2010; Mbizvo & Phillips, 
2014; Sullivan et al., 2006).  Women in SSA are not given the opportunity to consider all forms 
of mC before deciding upon the most appropriate method for their fertility preferences.  A low 
mC prevalence rate, combined with high unmet need in SSA, points to the region’s limitations in 
providing comprehensive FP services. 
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2.2 THE IMPORTANCE OF FAMILY PLANNING IN DEVELOPMENT 
Family planning is immediately relevant to development because it influences the birth rate and 
population growth rate of a country, and therefore has far reaching impacts on economic, social, 
and environmental well-being in society (Fabic et al., 2015; WHO, 2015a).  Sound development 
policies recognize not only the importance of investments in population health and education, but 
in FP programs as well to provide information and access to mC so that couples can achieve their 
fertility preferences. 
In 1999, the Centers for Disease Control and Prevention (CDC) named family planning 
one of the ten greatest public health achievements of the century, for not only health, but also 
social and economic benefits for both woman and family (Tsui et al., 2010).  Research from 
various studies finds FP interventions to be highly cost-effective as they reduce the future health 
care costs associated with unintended pregnancies and the transmission of sexually transmitted 
infections (STIs) and HIV/AIDS (Tsui et al., 2010).  Global data suggest that the increase in mC 
use within the past six decades in developing countries is responsible for 75 percent of the 
fertility decline seen there (Cleland et al., 2012).  In 2008, mC use prevented 250,000 maternal 
deaths secondary to unintended pregnancy.  Maternal deaths could be reduced by an additional 
30 percent if all the women living in the developing world were able to access mC (Cleland et 
al., 2012).  Using FP methods to properly space births could result in a ten percent reduction in 
child deaths (Cleland, 2009).  Seventy five percent of the eight million unsafe abortions that 
occurred in 2008 in women ages 15 to 24 could have been prevented had access to mC been 
available (Krashin et al., 2015). 
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2.2.1 Maternal and Child Health 
In the developing world, gains in FP and SRH have been tremendous over the past few decades; 
between 1990 and 2013 the maternal mortality rate decreased from 380 to 210 per 100,000 live 
births, a 45 percent reduction (Snow et al., 2015). 
There are two primary ways in which family planning reduces maternal and infant 
mortality: (1) it reduces the rate of unintended pregnancy and secondary complications from 
birth, miscarriage, and abortion; and (2) it reduces the associated risks of pregnancies that are 
“too early, too late, too many, [or] too close” (Brown, Ahmed, Roche, Sonneveldt, & Darmstadt, 
2015, p.  339).  Women are considered at higher risk for maternal and child mortality if they 
become pregnant at a certain age (i.e., younger than 18 or older than 35), have had more than 
three previous pregnancies, and have had their previous pregnancy less than 24 months prior to 
the current one (Brown et al., 2015).  Essentially, the more births a woman has over her 
reproductive lifespan puts her at an increasingly higher risk as she ages and her body repeatedly 
weathers the process of pregnancy and birth.   
For the infant, spacing pregnancies by a safe interval (recommended 24 months) 
decreases the risk of premature birth and low birth weight (Cleland et al., 2012).  Children born 
less than two years apart from one another have a 60 percent greater chance of dying in infancy 
than those who are greater than two years apart in age (Cleland et al., 2012).  Childhood stunting 
and chronic undernourishment also increases with shorter birth intervals (Maternal & Child 
Health Integrated Project, 2013).  Improving child survival through safe spacing and reducing 
risky pregnancy is described as a powerful stimulant for fertility decline, as parents no longer 
feel the need to have more children to protect and ensure against potential future child deaths 
(Casterline, 2010).  Child survival also increases when a woman has fewer children as the risk of 
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infectious disease transmission decreases, and there is less competition over shared household 
resources including food, health care, and nurturing (Brown et al., 2015). 
2.2.2 Educational Achievement 
Improved FP and SRH care results in increases in children’s schooling, as well as the ability for 
women to continue their own education (Singh et al., 2014).  Children from poorer and larger 
families often complete less schooling, as the parents cannot provide the necessary resources 
(e.g., uniforms, textbooks) to enroll all their children (WHO, 2015a).  Improved FP and SRH 
care means that there will be fewer dependent children per working-aged adult, thereby 
increasing household resources that each family can dedicate to their children (Singh et al., 
2014).  Societies with a large youth population also experience poor quality of schooling due to 
reductions seen in national spending per student (Casterline, 2010).  Essentially, the government 
in a developing country has a finite and limited amount of funding reserved for national 
educational programming.  Public sector provision of primary and secondary education can be 
overwhelmed if the country’s youth population is so large that the state cannot support the 
expenditures needed to adequately cover the cost of each student’s schooling (e.g., teacher’s 
salary, school infrastructure, classroom supplies). 
2.2.3 Poverty Alleviation  
A high fertility rate means that mothers are expected to stay at home and tend to the many 
children and households responsibilities, lessening their economic productivity and ability to 
participate in the workforce.  Countries with high population growth rates have a very large 
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number of young people, or so-called dependents, which are a net drain on a country’s 
productivity (Singh et al., 2014).  Population pressures overwhelm social services and health, 
education, and public infrastructure systems and can push families into further poverty  
(Bongaarts, 2015; Singh et al., 2014).   
The long-term benefits of investment in FP and SRH include GDP growth and poverty 
alleviation through gains in women’s earnings, household savings, and assets (Singh et al., 
2014).  When women are able to access FP services and delay childbearing until desired, they are 
more likely to escape poverty for themselves and their families through meaningful participation 
in income-generating activities (Mbizvo & Phillips, 2014).  One WHO study in 2013 found that 
a five dollar increase in SRH expenditure per person in 74 countries with very high maternal and 
child mortality could produce nine times that amount in economic benefits through heightened 
worker productivity (Singh et al., 2014).  With fewer children, parents can invest more money 
and time in health, education, and nutrition that influence a child’s overall development, 
educational success, and income later into adulthood (Canning & Schultz, 2012).  In SSA, where 
land is often inherited by sons from their fathers, fewer children means more land to inherit per 
child, ensuring higher crop yields per family in the future.  Fertility decline also means that land 
used for agricultural purposes can be appropriately sustained and will not be over-used or 
exploited (Casterline, 2010).   
2.2.4 Female Empowerment  
Participants in the 1994 International Conference on Population and Development (ICPD) 
strongly promoted the right of couples and individuals to determine the size and timing of their 
own families.  The ICPD stressed that individuals should be provided with necessary FP and 
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SRH information, and reproductive decisions should be free from discrimination, coercion, and 
violence (United Nations Population Fund, 2008).  SRH rights are fundamental to an individual’s 
well-being (Cleland, 2009; Singh et al., 2014).  Access to FP services that offer mC furthers 
gender equality by “freeing women from an incessant cycle of pregnancy, breastfeeding, and 
child care” (Cleland et al., 2012, p.  154).  Women’s autonomy and self-esteem are improved as 
they are able to determine, frequently with their partner’s input, their desired number of children 
and when in life to have them (Singh et al., 2014).  FP furthers gender equality by improving a 
woman’s general position and status in the social and economic affairs of her community 
(Canning & Schultz, 2012).  With fewer childrearing responsibilities at home, she is free to 
venture out into the world and involve herself in economic, social, or other pursuits she so 
chooses. 
2.3 MODERN METHODS OF CONTRACEPTION 
Contraception includes the use of particular sexual practices, devices, chemicals, or surgical 
procedures to intentionally prevent conception.  Contraception should maximize comfort and 
privacy, while minimizing cost and health side effects (Jain & Muralidhar, 2011).   
Major forms of mC can be divided based on their length of protection: short- or long-
term, and permanent.  It is important to note that efficacy of mC varies based on differences in 
the typical and perfect use failure rates.  Typical use refers to the probability of pregnancy in one 
year with users who follow different rates of adherence, while perfect use entails the probability 
of pregnancy in one year with users administering the method correctly and consistently every 
time (AAP, 2014).  All mC methods are more efficacious under perfect use conditions; however 
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it is more common for the user to approach the higher typical use failure rate, as mistakes in 
using the various methods are common (Boonstra, 2013).   
The most efficacious forms of mC require the least degree of user adherence; that is to 
say, how much involvement the individual must have in using the method (AAP, 2014).  As 
such, long-acting and permanent methods (LAPMs) are inherently more efficacious than short-
acting mC due to the lower level of action required by the user to keep the method performing as 
needed (Blumenthal et al., 2011).  In fact, the American College of Obstetricians and 
Gynecologists (ACOG) states that long-acting methods are 20 times more effective than short-
acting methods including the pill, patch, and ring over the long term (ACOG, 2014).   
In addition, traditional methods not included in this discussion but widely used are 
withdrawal (i.e., coitus interruptus or “pull out method”), abstinence, fertility 
awareness/calendar-based methods, and lactation amenorrhea method (i.e., breastfeeding as birth 
control).   
2.3.1 Short-Acting Reversible Contraception 
Short-acting reversible contraception provides continuous protection against pregnancy for any 
amount of time less than one year in length.  There are two major categories: (1) non-hormonal 
barrier methods that provide protection for just one sex act; and (2) hormonal methods that 
protect for anywhere from one to three months’ time. 
2.3.1.1 Non-Hormonal Methods 
Short-acting non-hormonal barrier methods include the male and female condom, diaphragm, 
and contraceptive sponge.  Most of these methods are used in combination with a spermicidal 
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agent to prevent the sperm from successfully moving from the vagina into the uterus and beyond.  
As the name suggests, barrier methods work by creating a physical barrier between the sperm 
and unfertilized egg.  Unlike hormonal methods, these forms do not prevent ovulation nor do 
they thicken the cervical mucus, making it more difficult for the sperm to reach the egg.  It is 
important to note that the male and female condoms are also effective in the prevention of STI 
and HIV transmission (WHO, 2015a).  None of the hormonal methods have this added 
advantage.  While the condom and sponge can be purchased without medical consultation, the 
diaphragm must be fitted to the size of the cervix, requiring at least one visit to a medical 
provider prior to use.  Users must also be aware of any personal allergies they may have to latex 
or other plastics or chemicals used in spermicides, which would preclude them from using such 
methods (Planned Parenthood Federation of America, 2014f).   
Generally, non-hormonal methods have higher typical and perfect use failure rates due to 
frequent errors in user adherence.  Efficacy is directly related to correct and consistent usage; 
problems arise if users do not know how to properly place the method in or on their body, or 
forget to use it each time they have sexual intercourse.  Still, individuals may choose to use these 
methods, as they do not interfere with the body’s natural hormone levels.  For some, the use of 
hormonal methods induces uncomfortable side effects that they are unable to tolerate or accept 
(AAP, 2014). 
The male condom is one of the more frequently used non-hormonal mC methods by both 
men and women.  This condom is referred to as “male” because it is a latex sheath that is 
unrolled over the male external genitalia (the penis) (Jain & Muralidhar, 2011).  Advantages to 
using this method include its low cost, ease of accessibility for youth, and involvement of male 
partners in contraception (AAP, 2014).  However, this method has a much higher typical use 
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failure rate (18 percent) compared to hormonal methods because it must be correctly used for 
each sex act, which is difficult as various individual and interpersonal level factors make it 
challenging for perfect user adherence (AAP, 2014).  Generally, medical providers stress the 
importance of practicing dual contraception; that is to say, using a barrier method in addition to a 
hormonal method to most effectively prevent pregnancy and STI/HIV transmission (WHO, 
2015a). 
The female condom is similar to the male condom in form and function, except for the 
difference of placement.  This condom is a polyurethane sheath meant to provide a barrier 
between sperm and egg, but is placed inside the female internal genitalia (the vagina).  The 
female condom has a set of firmer plastic rings; the one at the closed end is inserted into the 
vagina and sits snugly at the top of the cervix, while the other is purposely left outside the 
vaginal opening during intercourse (Jain & Muralidhar, 20011).  Female condoms have a higher 
typical use failure rate than male condoms (21 versus 18 percent), and are generally less popular 
than their male counterpart (AAP, 2014).   
The diaphragm is a silicone cup that is inserted into the vagina prior to intercourse, and 
works by covering the cervix.  This method requires a visit to a medical provider to be properly 
fitted.  It is typically used in conjunction with a spermicide that is applied to the inside and rim of 
the diaphragm.  It can be inserted hours before intercourse, which makes it more discreet than 
other non-hormonal methods.  It must also be kept in the vagina for at least six hours (but no 
more than 24 hours) after intercourse, to ensure that sperm are unable to enter the uterus.  Users 
must become comfortable with the insertion and removal of the diaphragm, and must keep it 
clean to prevent infection.  As mentioned, diaphragms come in different sizes that are unique to 
each woman’s body, and may need to be resized after childbirth and other bodily changes.  A 
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diaphragm can last for up to two years (PPFA, 2014f).  Typical use failure rates are moderate at 
12 percent (AAP, 2014). 
The contraceptive sponge is a circular foam sponge that has been impregnated with 
spermicide.  It is wetted and inserted into the vagina prior to intercourse, and works by creating a 
barrier over the cervix while preventing sperm motility.  The sponge must also remain in the 
vagina for at least six hours after intercourse (but no more than 30 hours).  The sponge does not 
require the user to see a medical provider for a prescription or fitting.  However, the sponge can 
be used only once before it must be thrown away (PPFA, 2014d).  Typical use failure rates 
depend on the user’s parity; for nulliparous women the failure rate is 12 percent, while for parous 
women it is a relatively high 24 percent (AAP, 2014). 
2.3.1.2 Hormonal Methods 
Short-acting hormonal methods include the combined oral pill, transdermal patch, vaginal ring, 
and DMPA injectable.  These methods prevent ovulation and thicken cervical mucus, making it 
more difficult for sperm to permeate the cervix and reach the uterus.  All of these methods share 
common side effects within the first few months of use: irregular bleeding (i.e., spotting), 
nausea, headache, dizziness, breast tenderness, weight gain or loss, and changes in libido and 
mood.  These methods also provide non-contraceptive benefits to users including improvements 
in acne, reduction in the duration and heaviness of menstrual bleeding, and lessening of cramps 
and other symptoms of premenstrual syndrome (PMS).  Users also enjoy their discreet nature 
compared to the potentially disruptive nature of using non-hormonal barrier methods prior to 
sexual intercourse (PPFA, 2014a; 2014b; 2014c; 2014e).   
 With short-acting hormonal methods, a user can have greater peace of mind against 
unintended pregnancy, but still needs to use a barrier method to prevent STI/HIV transmission 
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(WHO, 2015a).  Backup barrier methods (e.g., male or female condoms) must also be used 
within the first week after starting a hormonal form of mC to prevent pregnancy while the body 
adjusts.  Typical use failure rates for all of these methods, save the DMPA injectable, are at 9 
percent.  The injectable has a slightly lower typical use failure rate at 6 percent (AAP, 2014). 
Combined oral contraceptive pills include a combination of progestin and estrogen 
hormones that are ingested and absorbed into the bloodstream (WHO, 2015a).  If the user is 
sensitive to estrogen, a progestin-only pill is available.  Users must remember to take the pill 
around the same time every day; efficacy may be compromised if they skip a dose or are unable 
to keep it in their digestive system long enough for the hormones to be properly absorbed (Jain & 
Muralidhar, 2011).  Pill packs typically come in a 28-day formulation; three weeks are active 
hormone pills, and one week contains placebo pills that may be fortified with iron.  This placebo 
week is when the user will experience withdrawal bleeding from the dip in hormone levels 
before beginning a new pill pack for the following cycle (PPFA, 2014b). 
The transdermal patch also contains a combination of estrogen and progestin hormones, 
infused into a square adhesive patch and placed on the user’s stomach, shoulder, upper arm, or 
lower back for three consecutive weeks (AAP, 2014).  This is followed by one week when the 
patch is removed, with the user experiencing withdrawal bleeding, before beginning a new cycle 
by placing a fresh patch on the skin.  The hormones contained on the patch are slowly released 
over the course of three weeks, being absorbed through the skin and into the bloodstream in the 
same manner as other hormonal methods (PPFA, 2014a).  Users must keep the patch firmly 
affixed to the skin for the duration of the cycle; efficacy can be compromised if it is not kept in 
its proper place.  Unique side effects of the patch include adverse dermatologic responses to the 
adhesive or medication being kept in contact with skin (AAP, 2014). 
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The vaginal ring contains another combination of estrogen and progestin hormones, this 
time impregnated into a flexible plastic ring and inserted into the vagina where it stays for three 
consecutive weeks while releasing hormones.  It is removed for one week, during which time the 
user experiences withdrawal bleeding, before beginning a new cycle with a new ring (AAP, 
2014).  Users must be aware of how to properly insert the ring into the vagina for best fit; 
movement and expulsion may be possible during sexual intercourse and other daily activities.  
Still, users report that their partners generally cannot feel the ring during intercourse and it is 
highly discreet.  However, if the ring does come out, the user can simply clean and reinsert it into 
the vagina within 48 hours to maintain its efficacy (PPFA, 2014e).   
Progestin-only injectables require that the user receive a single injection, typically in the 
upper arm, every 12 weeks.  The injection provides very effective contraception for three 
months’ time with no daily or weekly adherence rituals like the pill, patch, or ring require 
(PPFA, 2014c).  This form of short-acting hormonal mC requires the least degree of user 
adherence, and has a typical use failure rate (6 percent) lower than all other short-acting 
hormonal methods (AAP, 2014).  However, the method requires that the user visit a medical 
provider to receive the injections at a routine interval, or else the efficacy of the shot may be 
compromised.   
2.3.2 Long-Acting Reversible Contraception 
Long-acting reversible contraception (LARC) provides continuous protection from pregnancy 
for more than one year’s time, without active user adherence, and includes the progestin implant 
(i.e., two-rod implants Jadelle and Sino-implant, and one-rod implant Implanon and Nexplanon), 
copper intrauterine device (IUD), and levonorgestrel intrauterine system (LNG-IUS) (Espey & 
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Ogburn, 2011; Jacobstein, 2007).  The two hormonal forms of LARC, the progestin implant and 
LNG-IUS, have mechanisms of action that are similar to short-acting hormonal mC (i.e., 
thickens cervical mucus, reduces sperm motility, prevents ovulation). LARC methods have 
grown in popularity in the developed world as the safest and most effective methods of reliable 
contraception among women looking to avoid an unintended pregnancy (Hathaway et al., 2014).  
LARC is praised for having both low failure rates and high continuation rates, making it second 
only to permanent methods (i.e., male and female sterilization) in this regard (Espey & Ogburn, 
2011).  LARC methods are also far more cost-effective over the long term, as opposed to other 
more commonly delivered forms of hormonal contraception that are more prone to incorrect or 
inconsistent use (Family Planning 2020, 2015b).   
LARC methods have typical use failure rates that approach perfect use failure rates, as 
user adherence is guaranteed once inserted (Doyle, Stern, Hagan, Hao, & Gricar, 2008; Pile et 
al., 2007).  LARC methods do require a visit to a trained medical provider for screening, 
insertion, and removal (Blumenthal et al., 2011).  Even so, LARC provides continuous 
contraception for up to ten years, and can be easily inserted by a medical provider after birth, 
miscarriage, or abortion, when women are already present at a health center (Bluestone, Chase, 
& Lu, 2006).  In fact, insertion and removal procedures can be undertaken in a single medical 
visit, with most procedures taking just a few minutes, and can occur during any time in the 
menstrual cycle (Espey & Ogburn, 2011).   
LARC is appropriate for most women, meaning that adolescents and women who are 
breastfeeding, HIV positive, and nulliparous are typically able to use this form of mC (Family 
Planning 2020, 2015b).  LARC is discreet (i.e., no one can tell you are using it), and does not 
interfere with sexual intercourse or other daily activities.  Once a LARC method is removed, a 
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woman’s fertility will return within weeks to months thereafter (ACOG, 2014; Gold & Johnson, 
2008).  LARC methods have few contraindications, meaning that most women are eligible to use 
them (ACOG, 2011).  Still, medical providers should consult the WHO and CDC guidelines that 
dictate medical eligibility criteria (MEC) for LARC method use (Jacobstein, 2007).  Generally, 
implants are considered a “Category 1” under the MEC, meaning that there are no restrictions on 
use.  The IUD and LNG-IUS are also rated “Category 1” (no restrictions) or “Category 2” 
(generally recommended) for most women (Family Planning 2020, 2015b). To protect against 
the transmission of STIs or HIV/AIDS, LARC users must use a barrier method (e.g., male or 
female condom), as the LARC device itself does not provide this type of protection (Boonstra, 
2013).  See Appendix B for a table comparison of the differences between LARC methods. 
2.3.2.1 Progestin Contraceptive Implant 
The contraceptive implant is a plastic single or double rod device just 4 cm in length and 2 mm 
in diameter that comes in a preloaded and disposable applicator (ACOG, 2011).  Rods contain 
the progestin etonogestrel that is released into the bloodstream (Reproductive Health Supplies 
Coalition, 2013).  Insertion involves a very minor surgical procedure, in which an incision is 
made in the inside of the upper arm to deposit the device using the preloaded applicator (Ladipo 
& Akinso, 2005).  The implant works similar to the ring, patch, and injectable, by suppressing 
ovulation and thickening cervical mucus (Jain & Muralidhar, 2011).  Implants provide three to 
five years’ worth of protection, and are easily removed by having another brief surgical 
procedure completed by a trained medical provider (ACOG, 2014).  This method is the most 
effective LARC method with typical and perfect use failure rates of 0.05 percent.  
Discontinuation rates are low; women who do choose to have the device removed typically do so 
because of the common side effect of unpredictable bleeding (AAP, 2014).   
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Complications during insertion are uncommon, but may include difficulty in completing 
the procedure correctly, pain, bleeding, and hematoma (ACOG, 2011).  If the device is broken or 
migrates in the arm, the removal process may also be complicated.  Common side effects include 
irregular bleeding and other hormonal side effects including headache, nausea, breast tenderness, 
and mood changes that may last for a few months following insertion (ACOG, 2014).  Irregular 
bleeding is the most cited reason for discontinuation of this method in the first year (Blumenthal 
et al., 2011).  Non-contraceptive benefits include lighter or altogether absent periods, relief from 
dysmenorrhea, and prevention of anemia (Espey & Ogburn, 2011).  The WHO recently released 
a statement claiming no restriction for the use of progestogen-only implants for women living 
with HIV/AIDS and on antiretroviral therapy (ART) (WHO, 2015b).  This is encouraging news 
for SSA, where HIV/AIDS prevalence rates are upwards of 10 to 25 percent in some countries. 
2.3.2.2 Copper Intrauterine Device (IUD) 
The copper IUD is a small T-shaped plastic device wrapped with a copper wire that is inserted 
into the uterus by a trained medical provider following a pelvic exam (Patel, 2014).  It is the only 
hormone-free LARC method (Bluestone et al., 2006).  The device releases copper ions that 
inhibit sperm motility and viability, and damages or altogether destroys the egg (ACOG, 2011).  
The Food and Drug Administration (FDA) approves the copper IUD for 10 years of effective 
protection against pregnancy.  Both typical and perfect use failure rates are well below one 
percent (0.8 and 0.6 percent respectively) (Gold & Johnson, 2008).  Common side effects include 
post-insertion bleeding, pain, and abdominal cramps, followed by three to six months of irregular 
bleeding.  Women may experience heavier periods and worse PMS symptoms after insertion 
(ACOG, 2014).  Heavier periods and dysmenorrhea are the most cited reasons for 
discontinuation in the first year (Gold & Johnson, 2008).  The copper IUD can be used as 
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emergency contraception in certain scenarios.  Research has also shown its use has a protective 
effect against endometrial cancer (Espey & Ogburn, 2011).  The WHO supports the use of the 
copper IUD among women who are HIV positive and on ART (Bluestone et al., 2006).  MEC 
usually does not recommend its use among women with confirmed AIDS (Espey & Ogburn, 
2011). 
2.3.2.3 Levonorgestrel-releasing Intrauterine System (LNG-IUS) 
The LNG-IUS is a small T-shaped piece of plastic impregnated with levonorgestrel hormones on 
the stem.  Following a pelvic exam, the LNG-IUS is inserted into the uterus, where hormones are 
slowly released into the bloodstream (Patel, 2014).  Its mechanism of action against pregnancy is 
the same as the copper IUD; additionally, it thins the endometrial lining and thickness cervical 
mucus, also inhibiting sperm motility (ACOG, 2011).  The FDA approves the LNG-IUS for up 
to five years of protection.  Its typical and perfect use failure rates (0.2 percent) are even below 
that of the copper IUD.  Side effects include post-insertion bleeding, pain, and cramps, in 
addition to commonly experienced hormonal side effects (e.g., headache, nausea, breast 
tenderness) that may last for a few months following insertion.  However, many women with the 
LNG-IUS will have lighter periods, and some may stop menstruating all together (ACOG, 2014).  
LNG-IUS is also recognized as effective in treating menorrhagia, anemia, and pain associated 
with endometriosis (Gold & Johnson, 2008; Greene & Stanback, 2012).  Altered bleeding 
patterns and pain are the most cited reasons for discontinuation of this method in the first year 
(Blumenthal et al., 2011).   
MEC supports the use of LNG-IUS among women who are HIV positive and on ART; it 
is not usually recommended for use among women with confirmed AIDS cases (Espey & 
Ogburn, 2011).  It is important to note that while many women are fearful of the IUD and LNG-
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IUS perforating the uterus and causing severe health complications, the event is extremely rare 
(Patel, 2014).  In fact, the likelihood of perforation is less than one per 1,000 insertions (ACOG, 
2011).  The expulsion rate (i.e., how frequently the device is expelled from the uterus) ranges 
from 2 to 10 percent in the first year of use (ACOG, 2014).   
2.3.3 Permanent Methods  
Permanent methods include female and male sterilization (i.e., tubal ligation and vasectomy) that 
are non-reversible in nature.  Such procedures are suggested for those who have decided that 
they are ready to stop having children after reaching a desired family size.   
During tubal ligation, the fallopian tubes are cut, preventing an unfertilized egg from 
meeting sperm (Jain & Muralidhar, 2011).  The operation can be completed with no incision 
(i.e., hysteroscopy) or with minimal incisions made on the lower abdomen (i.e., laparoscopy).  
Women will still experience menstruation and hormone levels are not affected by this procedure 
(PPFA, 2014g).  During a vasectomy, the vas deferens are blocked, meaning that sperm cannot 
travel from the testicles into the seminal vesicle, preventing egg fertilization.  The procedure is 
minimally invasive; the incision made on the scrotum is very small, and a no-scalpel technique 
exists (PPFA, 2014h).  There is no interference with the ability to have an erection or ejaculate; 
the only difference following a vasectomy is that the semen will not contain sperm (Jain & 
Muralidhar, 2011).   
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3.0  METHODS 
To identify relevant FP interventions related to LARC provision in SSA, a literature search was 
conducted from December 2015 to January of 2016.  Searches were conducted for published and 
peer-reviewed studies in the following electronic databases: POPLINE, PubMed, Ovid, Scopus, 
PsycINFO, and Google Scholar.  Keywords used to search these database included Sub-Saharan 
Africa; Africa; reproductive health; sexual health; sexual health behavior; family planning; 
family planning programs; contraception; contraceptive implant; intrauterine device; 
levonorgestrel intrauterine system; pregnancy; unintended pregnancy; fertility.   
Additionally, the “grey literature” of non-academic work was accessed through searches 
of relevant FP reports found on the websites of major health INGOs.  These organizations 
included Family Health International (FHI) 360, Population Services International (PSI), Marie 
Stopes International (MSI), EngenderHealth, Jhpiego, PATH, Pathfinder International, Save the 
Children, the WHO, the United States Agency for International Development (USAID), the 
United Nations Population Fund (UNFPA), and the World Bank.  Proceedings from international 
meetings on FP and SRH, including the 2012 London Summit on Family Planning and the 
Family Planning 2020 global partnership, were also reviewed for their value. 
Articles met the inclusion criteria of this search if they were written in English and 
published between the years 2000 and 2015, reported substantive qualitative or quantitative 
information on service delivery and behavioral health communication outcomes related to a FP 
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intervention located in a country or countries within SSA, and specifically targeted women of 
reproductive age who had not previously considered or had access to LARC.  Exclusion criteria 
included any interventions not published in the English language, not taking place in SSA, and 
not seeking to introduce LARC methods to women of reproductive age.   
Initial screening for potentially relevant articles involved reviewing the title and abstract.  
Based on initial review, many articles were excluded due to their inability to meet the selection 
criteria.  Articles that passed preliminary screening were further examined in full text and 
considered for ultimate selection in the literature search.  Thirty articles passed initial review and 
were further assessed in their full text.  Ten of these 30 were eliminated due to their inability to 
meet the selection criteria (see Appendix A).  Twenty articles detailing ten family planning 
interventions in 16 countries in SSA ultimately met the inclusion criteria and were included in 
the literature review (see Appendix A).   
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4.0  RESULTS 
Twenty articles, covering ten interventions in 16 SSA countries met selection criteria for this 
paper.  Seven of the ten focused on IUD provision exclusively.  Just one intervention focused on 
the contraceptive implant, and the remaining two on both IUD and contraceptive implant 
provision.  Intervention outcomes are summarized in Table 1.  
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Table 1: Summary of Intervention Outcomes 
1. Kenya,  
National Campaign,  
2003–2006 
• IUD insertion doubled over implementation period 
2. Guinea,  
Mandiana District,  
2004 
• IUD insertion increased five fold over implementation period 
3. Guinea,  
Siguiri District,  
2004–2006 
• IUD insertions increased nine fold over implementation period 
4. Uganda,  
Four Districts,  
2005–2006 
• Provided 1,597 clients with a LAPM, but just 41 IUD 
insertions over implementation period 
5. Kenya,  
Kisii District,  
2005–2007 
• IUD insertion increased by 734 percent (58 up to 484 
insertions) over implementation period 
6.  Ethiopia,  
Amhara Region,  
2005–2007 
• IUD insertion increased by 86 percent (182 up to 338 
insertions) over implementation period 
7. PSI,  
Six Countries,  
2009–2010 
• Provided over 175,000 women with IUD over implementation 
period 
8. Ethiopia,  
Four Regions,  
2009–2013 
• Provided over 45,000 clients with contraceptive implant over 
implementation period 
9. Zambia,  
Four Provinces,  
2008–2009 
• Provided 33,609 women with LARC method over 
implementation period  
10. MSI,  
15 Countries,  
2008–2012 
• IUD insertions more than doubled, and implant provision 
increased nine fold, totaling 1.7 million implants inserted over 
five years’ time 
 
4.1 INTERVENTIONS FOR IUD PROVISION 
Seven interventions focused on IUD provision exclusively, and were implemented between 2003 
and 2013.  Countries represented include Kenya, Guinea, Uganda, and Ethiopia, and the SSA 
regional program under PSI.   
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Four of the seven interventions were conducted by the ACQUIRE (Access, Quality, and 
Use in Reproductive Health) Project, a five-year $150 million global initiative designed by 
USAID’s Office of Population and Reproductive Health to improve and increase use of SRH and 
FP services, focusing particularly on providing LAPMs (Jacobstein, 2007).  USAID awarded the 
INGO EngenderHealth with the contract lead in 2003, with partnership assistance from the 
Adventist Development and Relief Agency International (ADRA), CARE, IntraHealth 
International, Inc., Meridian Group International, Inc., and the Society for Women and AIDS in 
Africa (SWAA) (Taylor, 2008a).  The ACQUIRE Project took place in Guinea, Uganda, Kenya, 
and Ethiopia.  It had three program priorities: (1) increase FP choices and services available to 
clients; (2) increase client, provider, and community participation in FP; and (3) increase service 
site participation offering SRH and FP services (Jacobstein, 2007).  The ACQUIRE Project used 
its own Supply-Demand-Advocacy (SDA) program model to increase access, quality, and use of 
LARC methods.  The SDA model views all three components (i.e., ready supply, demand for 
services, and positive policy environment through advocacy) as necessary starting points for 
successful FP programming and client-provider interactions (Taylor, 2008b).   
4.1.1 Kenya, National Campaign, 2003–2006 
While the overall proportion of married Kenyan women using mC rose over the past three 
decades, use of the IUD dropped from 31 percent of the mC method mix in 1984 to just 8 percent 
in 2003 (FHI, 2006).  The Kenyan Ministry of Health (MoH) led a national campaign from 2003 
to 2006 in collaboration with major health INGOs that included FHI 360 and EngenderHealth’s 
AMKENI project (FHI, 2006).  The MoH wanted to reintroduce the IUD into the mC method 
mix to provide a more balanced national FP program.  Major campaign objectives included: (1) 
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increase public support for the IUD among various stakeholders (e.g., providers, clients, policy 
makers); (2) increase high quality IUD service delivery; and (3) increase public demand for the 
IUD (FHI, 2006).   
FHI 360 had previously conducted national assessments in 1995 on client and provider 
knowledge and attitudes towards the IUD.  These assessments proved helpful in understanding 
why the IUD had declined in use over the past decade and served as the basis for the national 
advocacy and education campaign (FHI, 2006). 
In regards to strengthening service delivery, the MoH first updated the national SRH 
training curriculum, which FHI 360 has determined to be out of date.  This curriculum was used 
to train 171 providers in IUD insertion, removal, and counseling.  The Kenya Family Planning 
Guidelines for Service Providers was also revised and incorporated newly updated WHO criteria 
for mC use.  FHI 360 tested an IUD screening tool with providers that functioned as a 
streamlined checklist to easily determine if clients meet the MEC for IUD use.  The MoH formed 
training and supervision teams at the provincial and district levels that were sent to supervise the 
pilot health facilities.  These teams built capacity through ensuring that pilot facilities receive 
sufficient supplies and training, including IUD kits that contained the standard supplies needed 
for performing the procedure (FHI, 2006).  The AMKENI project distributed 600 kits with IUD 
insertion and removal supplies by working with USAID and John Snow, Inc.’s DELIVER 
Project.  Campaign reliance on sporadic donor funding, unreliable transport services, and poor 
record keeping all made securing a ready supply of IUDs a great challenge (FHI, 2006).  FHI 
360 hoped the Kenyan government’s intent to write a line item into the national budget for FP 
supplies could ameliorate this campaign struggle.   
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To address bias and misinformation at all levels, the MoH launched a national advocacy 
campaign by working with medical professional associations to write policy briefs geared 
towards educating policy makers and providers.  These briefs were given to 2,600 individuals, 
and 400 attended subsequent district level IUD reintroduction meetings (FHI, 2006).  Advocacy 
efforts also included hosting provincial and national professional development and continuing 
medical education (CME) events that focused on the benefits of the IUD.  The AMKENI project 
led IUD “reintroduction meetings” in addition to insertion and removal training for its supported 
facility staff (FHI, 2006). 
A communication campaign sought to address potential client misinformation and 
provoke greater demand for IUDs.  The AMKENI project employed 500 behavior change 
communication (BCC) agents, who were community volunteers trained to provide IUD 
information through interpersonal means.  BCC agents held community meetings with men’s, 
women’s, and youth groups, reaching over 12,000 people and distributing 21,000 health 
education brochures (FHI, 2006).  The intervention was successful in increasing the number of 
sites that could provide IUDs from 18 to 68 over two years’ time.  The intervention also led to a 
doubling of new IUD users accessing services at 97 AMKENI supported facilities (FHI, 2010). 
4.1.2 Guinea, Mandiana District, 2004 
The eight-month intervention in the Mandiana district of Guinea was a collaborative effort 
between Save the Children, the Guinean MoH, and FHI 360 (FHI, 2010).  Major intervention 
objectives included: (1) increasing awareness and support for the IUD; (2) improving IUD 
service delivery; and (3) expanding access to IUD services (FHI, 2008).  Save the Children had 
worked in the region since 1997, and recognized that many district women did not have access to 
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health facilities with FP services.  Low awareness and misinformation about the IUD was 
common among both women and providers (FHI, 2008).   
Save the Children began first by forming partnerships with various stakeholders 
including religious and community leaders and local NGOs, asking for their recommendations 
on IUD expansion in the district (FHI, 2010).  “Advocacy days” were designed to inform and 
gather support for the IUD among these various community level leaders (FHI, 2008).  Over the 
eight-month period, nine public awareness campaigns brought messages to district villages about 
the benefits of IUDs.  These messages were included in community organized plays and folklore 
rituals, in addition to local radio spots that featured IUD promotional messages, songs, and 
satisfied user testimonials (FHI, 2008).  Passionate community members were selected on the 
basis of previous FP promotion, and trained as BCC agents to engage potential clients and offer 
referrals to clinics that provided FP services.  These agents also held weekly village meetings 
where they spoke about the benefits of the IUD (FHI, 2008).   
 The INGO EngenderHealth trained district level providers and health department 
supervisors in IUD insertion and removal, FP counseling, and infection prevention techniques 
(FHI, 2010).  To manage and assist these trained providers, a supervision team was created.  
Save the Children worked to improve service delivery at four total district locations: two existing 
urban health center sites (where IUD services had previously been weak) and two new rural sites 
where IUD provision had never been available (FHI, 2008).  Additionally, the intervention was 
able to strengthen FP counseling and IUD referral services at nine more sites.   
In total, women from 113 villages benefitted from the intervention and IUD insertion 
increased by a factor of five in the four chosen locations (FHI, 2008).  Follow-up monitoring 
found that IUD use remained high 15 months after the brief intervention ended, and providers 
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were maintaining international standards for IUD insertion and removal, in addition to the 
necessary supplies to perform the procedure (FHI, 2008).   
4.1.3 Guinea, Siguiri District, 2004–2006 
Use of LAPMs in Guinea has historically been limited.  In partnership with the Guinean MoH, 
the ACQUIRE Project employed its Supply-Demand-Advocacy (SDA) program model to 
increase both awareness and access to LAPMs, and improve MoH capacity to provide the IUD in 
the Siguiri district (The ACQUIRE Project/Engender Health, 2008). 
Supply side activities included training providers in the provincial hospital and six 
additional health centers in IUD insertion and removal, FP counseling, and infection prevention 
techniques (The ACQUIRE Project/EngenderHealth, 2008).  The ACQUIRE Project described 
its training as a “whole site approach,” conducted with the entire site team (e.g., providers, 
administrators, staff), where needs are determined using a self-assessment tool, and supervision 
accompanies instruction (Taylor, 2008b).  This method was thought to be more sustainable than 
training individuals, as the site team could still deliver services if someone was off-duty or 
absent.  The ACQUIRE Project also assisted in developing and distributing useful clinical tools 
including job aids and standards of practice.  Although no formal training of trainers was 
conducted, trainees were encouraged to share their knowledge with others (Taylor, 2008b).   
To better understand its audience, project staff conducted client interviews and focus 
groups in urban and rural locations with men’s and women’s groups, religious leaders, and 
providers.  Results showed positive attitudes towards using mC for spacing, but not limiting 
childbearing, as the Guinean culture (and prior government regimes) had stressed the importance 
of large families (Escandon, Diallo, Toure, Mach, & Bunce, 2006).  The research also found that 
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health care workers, who were seen as trusted sources of information, heavily influenced 
women’s FP decision-making.  Results from this preliminary research informed the later 
communication campaign and community outreach activities (Escandon et al., 2006).   
A Guinean advertising agency was hired to develop the creative concept for the 
communication campaign, which was pre-tested among focus groups of varying demographics.  
The chosen key message that tested well with groups translated to “an ideal contraceptive for 
spacing births” (Taylor, 2008b).  The primary audience of this campaign was married women 
ages 25 to 40, while the secondary audience included married men with multiple wives, 
providers, and religious leaders.  Communication outputs included 500 print posters, 2,700 
brochures, and radio programs; imagery included a traditional Muslim family, a wealthy modern 
family, and a lone woman all communicating support for the IUD.  The campaign stressed the 
effective and discreet nature of the IUD, ease of use, duration of use, and minimal side effects.  
Combinations of the local languages and national language (French) were used in information, 
education, and communication (IEC) materials.  Radio programs included roundtable 
discussions, which featured various interviews with providers, satisfied users, and community 
leaders.  Interpersonal communication involved trained animatuers or community motivators 
who spread awareness around the IUD during community meetings, reaching an estimated 
12,000 people (Taylor, 2008b).  Lastly, a respect for religious custom was important for creating 
a supportive LARC environment in Guinea.  Inclusion of Muslim leaders figured prominently in 
this intervention; The ACQUIRE Project hosted a two-day meeting with the League of Islamic 
Affairs to elicit their support (The ACQUIRE Project/EngenderHealth, 2008).   
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Between 2004 and 2006 the number of IUD insertions increased nine fold (The 
ACQUIRE Project/EngenderHealth, 2008).  In addition, the reported number of new IUD users 
remained higher than pre-intervention figures in years following (Taylor, 2008b). 
4.1.4 Uganda, Four Districts, 2005–2006 
Over the years, the use of LAPMs had decreased in Uganda and in 2005 only 3 percent of 
women who used mC chose a LARC method.  The ACQUIRE Project in partnership with the 
bilateral USAID program UPHOLD and the Ugandan MoH led the intervention across four 
districts of Uganda, and sought to increase the capacity of 17 sites that offered a LAPM, in 
addition to the use of IUD services (Subramanian, Farrell, Kakande, Kumar, Johri, & Gutin, 
2008).  Project staff would increase use through providing technical assistance and educational 
outreach, involving males in FP dialogue, and collaborating with key stakeholders and other 
district agencies working in FP and SRH.  The so-called “district approach” sought to strengthen 
health clinic capacity, service delivery, training and supervision, and logistics, as well as achieve 
a sustainable and supportive policy environment for LARC moving forward (Subramanian, 
2008).  The ACQUIRE Project again used its SDA program model to focus on supply 
strengthening, demand creation, and advocacy efforts. 
District performance needs assessments (PNAs) found limited training and supervision 
capacity at district level health sites.  Project staff viewed PNAs as critical for both identifying 
gaps in service delivery and fostering a sense of project ownership and commitment from district 
participants (Taylor, 2008d).  Supply-side activities included: (1) training for MoH leadership 
and supervisors to improve management skills; (2) clinical trainings for providers on FP and the 
IUD; (3) IUD supplies and equipment delivery; (4) technical assistance for outreach activities 
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and referral systems; and (5) supervision and quality improvement training.  Trainings were 
followed up with routine visits to reiterate content and assess trainee knowledge (Taylor, 2008d). 
The communication campaign was limited (due to reduced funding) to just two of the 
four districts and focused on IUD promotion by stressing its unique benefits, safety and efficacy, 
and local availability.  Focus groups and client interviews helped project staff better understand 
its intended audiences.  The primary audience was women of low socioeconomic status, ages 18 
to 34, with at least one child.  Secondary audience members included spouses, policy makers, 
religious and community leaders, and providers.  The ACQUIRE Project hired a local Ugandan 
advertising agency to develop creative concepts that were pretested with focus groups; the 
chosen key messages were “Coil: Find out the Truth” and “Talk to your health worker about the 
Coil and other family planning options” (Taylor, 2008d).  Different sets of IEC print materials 
were made with urban and rural audiences in mind.  Community health worker (CHW) 
interpersonal engagement focused on spreading the word on IUD benefits, how it worked, where 
it could be obtained, and correcting common myths and misperceptions.  Three different radio 
spots aired for six months’ time (Taylor, 2008d). 
Policy and advocacy action included updating the national service delivery guidelines, 
and hosting district launch events to promote acceptance of the IUD within the greater Ugandan 
political and sociocultural environment (Taylor, 2008d).  The intervention provided 1,597 clients 
with a LAPM and was seen as a success as LAPM use was described as negligible in 2005.  
However, just 41 IUD insertions occurred over the two-year time period in the chosen districts 
where the communication campaign was held.  Though these results were disappointing, the 
ACQUIRE Project did find some validation in post-intervention group surveys that demonstrated 
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more positive attitudes towards FP services, and greater awareness of the IUD (Subramanian et 
al., 2008). 
4.1.5 Kenya, Kisii District, 2005–2007 
In Kenya, the IUD dropped in popularity from roughly 15 percent of the mC method mix in 1993 
to just 7 percent in 2003 (Taylor, 2008c).  The Kenyan MoH decided in 2004 to increase IUD 
access in seven districts with lower than average IUD utilization rates; the ACQUIRE Project 
lent assistance in Kisii District.  Project involvement was described as supportive in nature, 
assisting and complementing the MoH who led the initiative.  Four key issues in the IUD 
revitalization effort included: “(1) advocacy and sensitization; (2) capacity building and service 
delivery; (3) demand creation; and (4) monitoring/evaluation and operations research” (Rajani, 
2006, p.  2).   
The ACQUIRE Project and the Kisii district health authority began by conducting a 
PNA, holding focus groups, and interviewing providers at 13 district health sites, where they 
identified barriers to use, in addition to provider and client attitudes and knowledge towards the 
IUD (Taylor, 2008c).  To improve supply-side barriers and eliminate provider bias against the 
IUD, project staff updated and led clinical trainings on IUD insertion and removal procedures, in 
addition to FP counseling skills trainings for staff at 26 district health sites.  The ACQUIRE 
Project furnished sites with permanent equipment that included IUD kits and sterilization tools, 
while the MoH provided expendable supplies (Rajani, 2006).   
To increase demand, ACQUIRE staff hired a local Kenyan advertising agency to design a 
communication campaign that challenged IUD myths and misperceptions and promoted its 
safety and efficacy.  The target audience was potential IUD users, ages 25 to 40, who were 
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married with two or more children and interested in spacing or limiting births; secondary 
audience members included spouses, religious and community leaders, and providers, all 
described as key decision makers in the household and society.  The campaign slogan that tested 
well with focus groups translated to “know the truth about the IUD,” and featured accompanying 
imagery of satisfied female users and providers championing the method (Rajani, 2006).  This 
slogan was selected because focus groups liked its positive and proactive message, as well as 
accompanying imagery that depicted male engagement and couple interaction.  The 
communication campaign included radio spots, IEC print materials, and community outreach 
events with satisfied user testimonial.  All print materials prominently featured referral 
information (Taylor, 2008c).   
The radio campaign was unique in being careful to broadcast only into areas where IUD 
services would be available.  The radio spots were also broadcast in local languages during peak 
listening times, and a 15-minute weekly talk show held for six months’ time invited IUD 
champions to talk about their experiences and answer questions.  Community mobilization 
entailed interpersonal engagement with men’s and women’s groups, in addition to road shows.  
Road shows were referred to as “edutainment” events where marketplace dances, skits, and 
comedy became a fun and educational opportunity for the masses (Taylor, 2008c).  The MoH 
and ACQUIRE staff trained 74 community members to work as community peer educators and 
serve as sources of IUD information in their own villages.  “Community linkages meetings” 
were held prior to the launch of the communication campaign, so that all included stakeholders 
were briefed on its key messages (Rajani, 2006).  Again, the ACQUIRE Project held a launch 
event to promote the initiative, and invited prominent stakeholders, as well as members of the 
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media; the launch event was broadcast on national television, radio stations, and newspapers 
(Taylor, 2008c).   
While the MoH engaged in advocacy at the national level, including updating FP service 
provider guidelines, distributing IUD policy briefs to key stakeholders, and hosting IUD 
sensitization workshops, ACQUIRE staff focused its own advocacy efforts at the district and 
community levels by working with identified IUD champions (Taylor, 2008c).  At the end of the 
two-year intervention, IUD insertion in Kisii had increased by 734 percent (58 up to 484 
insertions), and insertion rates were still at very high levels one year later (Taylor, 2008c). 
4.1.6 Ethiopia, Amhara Region, 2005–2007 
Prior to the intervention, the Amhara region of Ethiopia had very few available FP services amid 
failing health infrastructure, and the IUD was cited as the least popular mC method (0.2 percent 
use) among women (Taylor, 2008a).  The ACQUIRE Project collaborated with the Ethiopia 
MoH to reintroduce the IUD and increase access, demand, and overall use of public and private 
sector FP services (Taylor, 2008a).  The Supply-Demand-Advocacy (SDA) program model was 
again introduced.   
Three hospitals and ten health centers were chosen to be the recipients of IUD service 
strengthening, achieved by improving providers’ clinical skills in IUD insertion and removal, FP 
counseling, and infection prevention techniques.  Seven hundred eighty community-based 
reproductive health agents (CBRHAs) and health extension workers (HEWs) were also trained in 
FP counseling and making referrals.  To assess competency, project staff routinely followed up 
with those who received training.  The ACQUIRE Project provided additional technical 
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assistance to improve service delivery channels and LARC procurement, and helped develop 
updated medical guidelines on IUD provision that agreed with MoH policy (Taylor, 2008a).   
To address demand side barriers, a communication campaign began by first connecting 
with key stakeholders working in the region (Taylor, 2008a).  A completed PNA found low 
literacy rates, high radio use, and limited mass media access in rural areas.  Prior research and 
interviews conducted in the area also discovered that limited knowledge and awareness regarding 
the IUD would be formidable barriers.  It was apparent that communication efforts, especially for 
rural areas, would need to be done at the local level through interpersonal means, and address the 
side effects, duration, effectiveness, and reversibility of the IUD.  The trained CBRHAs and 
HEWs were called upon to be leaders of a local campaign to target the rural and illiterate 
populations.  In this role, they were supplied with IUD technical booklets and branded clothing 
(e.g., t-shirts, baseball caps) so that potential clients could better identify them (Taylor, 2008a).   
The ACQUIRE Project chose women ages 18 to 34 as the primary target audience, with 
secondary audience members including politicians, community leaders, and other health 
workers.  A local Ethiopian advertising agency pretested a number of creative concepts with 
focus groups that represented these various audiences.  The chosen key message was “reliable as 
my choice…reversible when I decide” (Taylor, 2008a).  With this slogan in mind, the project 
produced two radio spots, four billboards, and 19,000 posters that were distributed to health 
centers and health workers.  Radio was seen as the most important channel due to its far reach 
and the fact that people did not need to be literate to understand it.  The billboards and posters 
were seen as complementary actions to increase overall visibility of the communication 
campaign.  Within the health facilities offering IUDs, signs, leaflets, and technical booklets were 
also produced to supplement IEC materials. 
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Advocacy efforts focused on gaining support and acceptance for the IUD from local 
politicians, community and religious leaders, other NGOs, and regional health officials.  The 
ACQUIRE Project held campaign launches in each region, to celebrate its efforts and draw more 
attention to key messages.  These events included testimonials by satisfied IUD users, in addition 
to promotional messages from providers that were proliferated through mass media outlets 
including both national and regional radio, television, and newspapers.  As a result, IUD 
provision in the region jumped by 86 percent (182 up to 338 insertions) from 2006 to 2008 
(Taylor, 2008a). 
4.1.7 Population Services International, Six Countries, 2009–2010 
The Women’s Health Project (WHP) of PSI was a two-year, 13-country initiative, with six SSA 
countries included: Kenya, Madagascar, Nigeria, Uganda, Tanzania, and Zambia (Blumenthal, 
Shah, Jain, Saunders, Clemente, Lucas, Jafa, & Eber, 2013).  The WHP’s objective was to 
stimulate demand and improve service delivery for the IUD among countries with high unmet 
need and low IUD utilization.  Across these six SSA countries, combinations of four PSI service 
delivery approaches were used: (1) private franchised clinics; (2) PSI-affiliated network clinics; 
(3) seconding (i.e., temporarily assigning) PSI staff to public sector clinics; and (4) outreach 
clinic “event days” (Blumenthal et al., 2013).  Within the first two approaches, PSI staff was 
generally responsible for training, monitoring, and supporting providers at these established 
health clinic sites.  PSI also implemented demand creation activities in the surrounding 
communities.  Members of the PSI-seconded staff were focused on building capacity at clinics 
through provider training on IUD insertion and removal, FP counseling, and infection prevention 
  43 
techniques.  These clinics were typically in areas with few private sector clinics, as well as 
poorly funded public sector FP services (Blumenthal et al., 2013). 
The fourth service delivery approach, referred to as “event days,” took place at advertised 
locations and was preceded by two to five days of community outreach activities centered on 
educating women about LARC and making referrals to nearby providers (Blumenthal et al., 
2013).  During these event days, outreach clinic staff screened women for medical eligibility and 
inserted their chosen LARC method over a one to three day timespan.  PSI was responsible for 
training the outreach clinic staff, monitoring foot traffic, and providing logistical support for 
supplies supervision (Blumenthal et al., 2013).  The general trend was to begin WHP service 
delivery in a given area with specially advertised event days, then gradually shift to more routine 
service delivery from static clinic settings as user awareness spread. 
Demand generation for LARC encompassed mass media and interpersonal 
communication campaigns that were led by CHWs trained as BCC agents.  These agents 
discussed LARC myths and misperceptions, benefits, side effects, client questions, and provided 
referral services.  Mass media campaigns also addressed these concerns in addition to providing 
more IEC content.  PSI used a variety of communication channels in each country, including 
radio, television, print materials, and billboards where available.  Monitoring and evaluation 
measures later found consumer demand for IUDs was greater than expected, and “low-tech 
demand generation approaches linking potential consumers to nearby service locations [were] 
highly effective” (Blumenthal et al., 2013, p.  173).   
PSI also engaged in advocacy with other NGOs working in the FP and SRH field, 
supporting the integration of IUD insertion and removal training in medical school courses and 
IUD education for private providers during national medical conferences.  In sum, over 175,000 
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women across SSA were counted as new IUD users thanks to the WHP (Blumenthal et al., 
2013). 
4.2 INTERVENTIONS FOR IMPLANT PROVISION 
One intervention focused on implant provision exclusively and was implemented from 2009 to 
2013.  This intervention was conducted in four regions within Ethiopia.   
4.2.1 Ethiopia, Four Regions, 2009–2013 
Ethiopian women rely primarily on short-acting mC, and LARC was historically limited due to 
various supply side barriers  (Asnake, Henry, Tilahun, & Oliveras, 2012).  The Ethiopian MoH 
partnered with the Integrated Family Health Program (IFHP), a five-year USAID-funded 
program led by Pathfinder International, John Snow, Inc., and the Consortium of Reproductive 
Health Associations (CORHA) to expand the mC method mix and include community-based 
provision of the Implanon implant (Asnake, Henry, Tilahun, & Oliveras, 2013).  Implant services 
in rural communities were scaled up through “task shifting,” giving competency training to 
health extension workers (HEWs) to provide implant services.  HEWs are paid community 
health workers who provide various health services at health posts located in each kebele 
(village).  Prior to this intervention, only hospitals and health centers with doctors or other highly 
skilled health personnel were allowed to provide implant services to interested clients (Asnake et 
al., 2012). 
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The IFHP sought key stakeholder participation by selecting 72 obstetricians and 
gynecologists, already trained in contraceptive implant insertion, to serve as “master trainers” for 
the 218 selected HEWs under the train-the-trainer (TOT) model (Asnake & Tilahun, 2010).  It 
was important that the trainer to trainee ratio be small so that one-on-one supervision could 
occur.  The IFHP and its partners created the training curriculum, IEC materials, and monitoring 
and evaluation methods for the intervention.  The training curriculum covered screening for 
medical eligibility, FP counseling, insertion and removal procedures, and infection prevention 
techniques (Asnake et al., 2011).   
To recruit enough women to serve as patients for HEW training sessions, the IFHP used 
“audio-visual vans” to raise awareness around the event and promote the FP services available 
(Asnake & Tilahun, 2010).  Village-level demand generation has three major parts: (1) HEWs 
informed community members of training days well in advance; (2) volunteer CHWs made 
community-wide announcements of dates and locations of training days; and (3) IFHP mobile 
staff were sent to villages five weeks in advance to also spread awareness via interpersonal 
communication (Asnake, Cole, Oliveras, & Tilahun, 2011).  During training sessions, clients 
were offered the full range of short- and long-acting methods if they ultimately did not choose to 
have Implanon inserted. 
This communication strategy resulted in more than 3,500 women participating as training 
session patients.  Trainings were part theoretical and part clinical practice; HEWs first practiced 
their technique on a wooden and plastic arm model before being allowed to perform it on an 
actual client.  Once the HEW was certified in implant insertion, he/she was provided with 20 sets 
of Implanon by the IFHP.  While the IFHP supplied resources for all HEW trainings, it left the 
MoH national supply chain and woreda (district) health offices responsible for maintaining 
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supplies thereafter (Asnake et al., 2011).  Regular follow-up meetings with master trainers and 
HEWs after the intervention start date helped IFHP staff better under progress and challenges 
they faced. 
 One of the main project priorities was ensuring community-wide access to implant 
removal services, when the time came for women to request them.  After all, Implanon is 
approved for three years’ time, and many women may decide to have the device removed 
prematurely if it causes an adverse reaction or they cannot tolerate the side effects.  The IFHP 
made implant removal services available through: (1) directly training over 1,500 providers in 
implant removal; (2) supplying health centers with implant removal kits; (3) providing back up 
support to 139 health centers, reaching 700 smaller health posts; and (4) building capacity at the 
woreda level to request implant removal support, equipment, and technical assistance from IFHP 
during the five-year implementation period (Asnake, Solter, Tilahun, & Vespia, 2013).   
The IFHP task shifting service delivery approach was eventually scaled up to reach 209 
of 550 woredas in the country, and provided over 45,000 clients with implants (Asnake et al., 
2011).   
4.3 INTERVENTIONS FOR IUD AND IMPLANT PROVISION 
Two interventions focused on IUD and implant provision, and were implemented between 2008 
and 2012.  One intervention took place in four provinces of Zambia, while the other described 
the SSA regional program under MSI.   
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4.3.1 Zambia, Four Provinces, 2008–2009 
Zambia has historically had a very low LARC use rate (0.4 percent) among women who use mC.  
This small-scale intervention was led by the Society for Family Health (SFH) in collaboration 
with PSI, the Zambian MoH, and USAID, which donated commodities, along with funding from 
an anonymous donor (Neukom, Chilambwe, Mkandawire, Mbewe, & Hubacher, 2011).  PSI 
hired and trained 18 midwives to promote LARC and provide same-day insertion services, 
placing them in public sector health clinics across four provinces to supplement preexisting FP 
services that primarily offered short-acting mC.  In fact, preliminary research found that most 
women who attended these busy clinics were often given short-acting mC without being asked 
about a longer-term need.  PSI staff suspected a “significant latent demand” (Neukom et al., p.  
450) for LARC services, and in response, brought in providers who were passionate about FP 
and SRH.  These 18 midwives boosted the total number of days that LARC services were 
available to nearby communities, and helped clinic staff gain competency in LARC counseling, 
insertion and removal procedures, and infection prevention techniques (Neukom et al., 2011).   
Midwives were rotated throughout the week between their primary clinics and more rural 
clinic locations.  In total, 23 different clinics across four provinces were served, with PSI 
providing ongoing supervision and support.  The intervention was unique in its choice to counsel 
women at the clinics who had arrived for other reasons; midwives spoke to these groups during 
their wait, touting LARC for its many benefits, while offering them the choice to try it that same 
day (Neukom et al., 2011).  Midwives could offer either the implant or copper IUD to their 
clients, and postpartum IUD insertion was also made available.  Clients were instructed to return 
whenever they desired for removal, and were given a card with information regarding their 
chosen method and its duration of use.  Midwives also asked for verbal feedback from LARC 
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clients during their visits to the clinics.  Collected feedback addressed the benefits, drawbacks, 
and misperceptions of LARC, and was presented to prospective clients while they waited for 
other MCH services at the clinic (Neukom et al., 2011).   
 Monthly LARC insertion grew from 287 in the first month to 3,756 in the busiest month 
of the intervention, an increase of roughly 1200 percent.  Over the 14-month implementation 
period, the midwives provided 33,609 women with LARC.  Interestingly, the implant was more 
popular than the IUD, with over two thirds of women opting for it (Neukom et al., 2011).   
4.3.2 Marie Stopes International, 15 Countries, 2008–2012 
MSI’s mission is “children by choice not chance” (May, Ngo, & Hovig, 2011, p.  4).  Three 
service delivery channels are used in MSI interventions in SSA: (1) MSI clinics; (2) mobile 
outreach; and (3) social franchising.  By using more than just one channel, the likelihood of 
reaching a potential user increases; MSI determines which channels to use based on efficiency 
and reach metrics within each country (Duvall, Thurston, Weinberger, Nuccio, & Fuchs-
Montgomery, 2014).   
Research collected from numerous exit interviews with SSA clients determined that the 
most influential source of information for a woman debating using MSI services was someone 
else who had previously used the service.  Additionally, the most important reasons for choosing 
MSI services were having them nearby and their good reputation (Duvall et al., 2014).  With 
these findings in mind, MSI strategy is to delivery quality FP services that produce satisfied 
users who will then refer their friends and neighbors, furthering promoting MSI services in SSA. 
MSI clinics have the longest history of service delivery in this region.  These clinics are 
run exclusively by MSI, located in urban (i.e., cities and towns) and semi-urban areas, and 
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provide FP services to 15 SSA countries (Duvall et al., 2014).  Importantly, these clinics have 
sliding scale fees, so that a portion of the collected revenue can then subsidize the mobile 
outreach services that are typically free to impoverished rural users.  Demand is generated 
through educational outreach conducted in community settings (e.g., markets, beauty salons, 
universities) by MSI clinic staff, in addition to radio advertisements, print flyers, and 
promotional IEC materials posted in visible places (Duvall et al., 2014). 
Mobile outreach brings MSI providers and LARC supplies directly to underserved clients 
every four to six weeks in rural locations.  MSI collaborates with public sector clinics selected on 
the basis of existing infrastructure, community ties, and the degree of clinic visibility among 
clients.  To generate demand for these services, CHWs conduct outreach with IEC materials, 
group information sessions, and village-level promotional efforts.  The day of the mobile 
outreach visit is widely publicized and announced beforehand on the radio or through local 
media advertisements (Duvall et al., 2014). 
Social franchising networks are contractual arrangements with private providers working 
in underserved areas that provide FP services and are regulated and supported by MSI.  This 
means that MSI-supported providers will have access to LARC commodities that they might 
otherwise not have.  This is done through: (1) MSI commodity price reductions; or (2) negotiated 
access to national level commodity supply chain support (Duvall et al., 2014).  Social franchising 
allows network clinics to provide reliable and affordable access to a wider range of mC that 
includes LARC.  Demand is generated through CHW educational outreach, print and radio 
advertisements, and financial promotions or “special discount days” for LARC services (Duvall 
et al., 2014).  MSI also coordinates LARC removal services at its clinics and franchisee 
locations; for outreach clients, referrals are usually made to a static clinic site for removal 
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services.  All staff and providers must attend MSI training on LARC insertion and removal 
procedures, FP counseling, and infection prevention techniques.  Refresher courses are routine 
and mandatory (Duvall et al., 2014).   
Between 2008 and 2010, IUD insertions in SSA more than doubled, and implant 
provision saw a nine-fold increase, totaling 1.7 million implants inserted over five years’ time 
(May et al., 2011).  The majority of the IUD and implant insertions were the result of mobile 
outreach that focused on poorer rural populations.  MSI attributes this scaling-up success to: (1) 
public-private partnerships; (2) social franchising and voucher schemes; (3) task shifting; and (4) 
concentrated rural outreach efforts (May et al., 2011).   
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5.0  DISCUSSION 
5.1 OBSTACLES TO EFFECTIVE LARC PROVISION  
There are various obstacles to effective mC provision.  In trying to obtain contraception, women 
may find laws or policies preventing their access (based on age, parity, or marital status and 
consent) or health providers that are in opposition to their use, in addition to potentially 
prohibitive costs and poor local service provision (Blumenthal et al., 2011; Greene & Stanback, 
2012; Vernon et al., 2007).  In using contraception, women may face unsupportive partners or 
spouses, in addition to peer pressure and social norms that discourages their use.  Stigmas around 
contraception, including the idea that a women carrying condoms is a prostitute or promiscuous, 
also exist (Williamson et al., 2009).  Generally, little knowledge of how to obtain or use mC 
correctly is common (Chandra-Mouli et al., 2014).   
5.1.1 Supply Side Obstacles 
5.1.1.1 Provider Bias  
In many cases, health care providers hold incorrect and outdated opinions of LARC methods 
based on their limited education on the subject (FHI, 2008; Subramanian et al., 2008).  In 
interviews conducted with providers, many felt uncomfortable promoting the method in 
consultation with clients because of their relative inexperience and insufficient training in the 
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insertion and removal of such devices (May et al., 2011; Rajani, 2006;).  Indeed, the Zambia case 
study found that FP providers who lacked meaningful supervision during training events had less 
confidence and desire to provide such services over time (Neukom et al., 2011).  With the IUD 
and LNG-IUS, providers most frequently worry that the device may cause pelvic inflammatory 
disease (PID), infertility, and be unsafe for women who are HIV positive (Jacobstein, 2007).  
However, none of these fears have any basis in fact; IUDs are not associated with an increased 
risk of PID, infertility, or danger for HIV+ women (Bluestone et al., 2006).   
Some health care providers have strong cultural norms against unmarried or adolescent 
women using contraception.  Indeed, one research study found providers often set unnecessarily 
high age and parity requirements for women based on their own bias or incorrect information 
around mC risk (Green & Stanback, 2012).  Providers and health officials may also show strong 
favoritism for short-acting reversible contraception, including the pill, condom, or injectable, 
because they are more familiar with counseling potential clients on these methods, and the inertia 
of having done so for many decades is harder to reverse (Neukom et al., 2011). 
5.1.1.2 Failing Health Infrastructure  
Hospitals and health clinics responsible for providing FP services were often found to lack the 
necessary equipment and supplies to functionally offer LARC methods to interested clients on a 
regular basis (FHI, 2006; Rajani, 2006; Taylor, 2008a).  The ability to provide sterile surgical 
conditions for LARC insertion and removal procedures may also be limited, and increase the 
likelihood of infection or other health complications (May et al., 2011; Taylor, 2008c).  
Additionally, health care providers may not have had clinical experience with LARC insertion 
and removal procedures because their medical school or facility was under-equipped to teach 
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such courses (Subramanian et al., 2008).  In some instances, providers and clinics may have the 
necessary tools to perform device insertion, but not device removal (Duvall et al., 2014). 
5.1.1.3 Weak Political Support  
Without the support of relevant policy makers, government officials can easily ignore requests 
for MoH funding and promotion of LARC in the national mC method mix.  Historically, short-
acting reversible methods have garnered greater attention from national ministries of health and 
governments in SSA (Neukom et al., 2011; Rajani, 2006).  In many countries, the historical 
political climate was ambivalent towards LARC, and some governments supported pronatalist 
policies as an economic development strategy (Subramanian et al., 2008; Taylor, 2008b).  
Political support should never be underestimated as an important component to effective LARC 
provision; in the case of Kenya the IUD was a popular mC method offered to women in decades 
prior, and had slowly disappeared due to cuts in MoH funding and attention placed on other 
prominent health issues (e.g., HIV/AIDS transmission) (FHI, 2006).   
In Uganda, researchers found that political commitment and written declarations on FP 
policies did not always align, and local-level leaders responsible for allocating public funds were 
not well informed of health sector or FP priorities at the national level (Subramanian et al., 
2008).  These problems had historically limited the national MoH to effectively offer the desired 
mC method mix to its citizens.  The ACQUIRE Project also stressed the importance of political 
will in the long-term success and viability of FP programs moving forward (Taylor, 2008b).   
5.1.1.4 Poor or Nonexistent Funding  
Poor funding is related to both weak political support and the unreliable nature of international 
donor commitments.  All of the interventions studied involved an implementing agency that has 
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tremendous clout and ample financial resources in the field of FP and SRH.  Still, interventions 
are inherently short-term in length (anywhere from a few months to five years’ time), and 
funding arrangements quickly dry up once program operations have ceased.  While the 
respective countries’ MoH may have the desire to expand the mC method mix to include LARC, 
they are often faced with the reality of little to no public funding for any ambitious public health 
intervention (Subramanian et al., 2008).  Again, international commitment and donations may 
focus on more pressing health concerns on the continent, which have recently included 
preventing HIV/AIDS and malaria, tuberculosis, and other infectious disease control measures 
(Jacobstein et al., 2009; Mbizvo & Phillips, 2014).   
5.1.1.5 Breaks in the Supply Chain  
For many interventions, when the demand for LARC at health clinics was strong, the materials to 
carry out implant and IUD insertion were often in short supply (Asnake et al., 2013; Rajani, 
2006).  In Uganda, the ACQUIRE Project referred to frequent “stock-outs,” due to limited 
finances at the national level to supply adequate equipment and LARC devices to health posts 
(Subramanian et al, 2008).  In rural SSA settings, it is often difficult to secure reliable 
transportation for goods through rough terrain that may involve washed-out roads or broken 
down rail systems.  The Zambian intervention reported that it could have reached more women if 
procuring the LARC commodities and supplies from national systems had not been so difficult 
(Neukom et al., 2011).  While stock-outs reduce service uptake, a ready supply of commodities 
ensures high-quality service delivery as well as greater client uptake and loyalty (Duvall et al., 
2014).   
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5.1.2 Demand Side Obstacles 
5.1.2.1 LARC Myths and Misperceptions  
Various myths and misperceptions exist among all SSA women interviewed in the interventions.  
In Kenya, women were fearful of the IUD migrating elsewhere in the body, harming a fetus, and 
causing pain or discomfort during sex (Rajani, 2006).  Women thought the IUD could cause an 
abortion and possibly rust inside of them (Bluestone et al., 2006).  Most interestingly, women in 
several SSA countries believed that if they became pregnant while using an IUD, the baby could 
be harmed or be born holding it (Melngailis & Eber, 2006; Taylor, 2008c).   
Myths and misperceptions also abound regarding personal health concerns (Blumenthal 
et al., 2013).  Some women stated fears of acquiring HIV/AIDS and other illnesses through the 
insertion process (Bluestone et al., 2006; FHI, 2006).  In Kenya, focus groups participants 
reported concerns that the IUD causes cancer, and weakens the body, making manual labor a 
challenge (Taylor, 2008c).  In Uganda, women were worried that an IUD could disappear in the 
body and cause prolonged bleeding (Taylor, 2008d).   
5.1.2.2 Little Knowledge of LARC  
In some instances, women had heard of the implant or IUD, but knew nothing about it beyond 
the name (FHI, 2008).  In research conducted by the ACQUIRE Project in Ethiopia, participants 
did not know much about LARC methods beyond their existence; they had neither favorable nor 
unfavorable views on its use, and could not describe how it worked (Taylor, 2008a).  In other 
cases, women may have known about LARC and wanted to try it, but were unfamiliar with 
where it could be obtained, its cost, and other questions of access (Escandon et al., 2006; Rajani, 
2006).   
  56 
5.1.2.3 Limited Access to Services  
Access, as defined by Cleland and Machiyama (2015) includes “information about [FP] method 
and services, geographic proximity to services, affordability, and acceptability” (p.  13).  Barriers 
to access may include cognitive, geographical, financial, sociocultural, and health care-related 
factors (Pile et al., 2007).  Prior to many interventions, LARC methods were available at only a 
handful of hospitals or regional health posts located primarily in more urban settings (FHI, 2008; 
2010).  For many women, the most convenient health clinic did not provide FP methods beyond 
popular short-term hormonal forms including the pill and injectable (Neukom et al., 2011).  
Indeed, for some interventions, LARC was being introduced for the very first time to areas 
where previously it had never been offered (Asnake & Tilahun, 2010; Blumenthal et al., 2013; 
Taylor, 2008a).   
Access also refers to the question of cost; if the cost of obtaining any mC is too high for 
the user to afford, she will likely go without.  During the IFHP implemented in Ethiopia, 
researchers also found that a significant barrier to access was the consent of husbands, mothers-
in-law, and family members to escort young married women while travelling to another town for 
FP services (Asnake et al., 2012).   
5.1.2.4 Social Stigma 
In general, many women believe that consulting providers about FP services may signal their 
promiscuity or, if unmarried, sexual activity before marriage (Singh & Darroch, 2012).  This 
stigma makes it difficult for women to discuss FP with their partners or obtain husband approval 
to access it; many women are afraid of their partner’s response to using contraception, and do not 
seek it out (or do covertly) for fear of reprisal (Prata et al., 2013).  Additionally, many African 
cultures stress the importance of large families; FP services may be viewed as counter to the 
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prevailing tradition and social norms (Escandon et al., 2006; Taylor, 2008b).  With shorter 
average life expectancies in many SSA countries, getting married and having children is a top 
priority for early life. Especially for newly married women, the pressure from peers and mothers-
in-law to quickly start a family and have many children is great, and mC use does not have 
community approval (May et al., 2011).   
5.2 EFFECTIVENESS OF LARC INTERVENTIONS  
5.2.1 Shared Intervention Strengths 
5.2.1.1 Engaging with Community Stakeholders First 
The most successful interventions were those that put forth effort to secure buy-in from relevant 
stakeholders within the country of operation.  This meant not only the political commitment from 
national leaders and health ministries, but also technical support from health care institutions 
(e.g., hospitals, clinics, medical schools), and most importantly, the trust of potential clients.  
Many INGOs engaged in advocacy at national, regional, and village levels, as they attempted to 
garner the high profile support of respected and influential community figures around LARC 
promotion (FHI, 2006; 2008; Taylor, 2008a).  Many interventions also worked directly with 
regional and local health care officials, national universities, and professional healthcare 
organizations to update medical eligibility guidelines, improve LARC service delivery, and 
strengthen provider training and supervision capacity (Asnake & Tilahun, 2010; FHI, 2006; 
Neukom et al.  2011). 
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Effective interventions recognized that collaboration with the national MoH, other health 
INGOs, community-based organizations (CBOs), political, community, and religious leaders 
early on in the intervention was imperative to project success.  Collaboration with key 
stakeholders, who were seen as “gate keepers” to accessing the population of interest, was a 
prominent component of the Save the Children Guinea intervention (FHI, 2008; 2010).  
Religious leaders are also particularly salient in countries where religion is central and one of the 
more visible forces in society.  For the ACQUIRE Project operating in Guinea, this meant 
engaging with imams in a public forum to increase the perceived social acceptability of LARC 
methods (The ACQUIRE Project/EngenderHealth, 2008).  In most cases, religious leaders 
(typically Christian or Muslim) were supportive of maternal and health objectives, including the 
ability to safely space children through the use of FP services.  
Participatory stakeholder engagement was also important for establishing a sense of 
ownership and responsibility for project goals.  The ACQUIRE Project and EngenderHealth 
conducted primary qualitative research (e.g., PNA, focus groups, client interviews) to better 
understand the target audience for their intended interventions.  Furthermore, the INGOs hired 
local advertising agencies to design communication campaign creative concepts and key 
messages, which were pre-tested with focus groups comprised of individuals that mirrored 
intended target audiences, to study how well messages were generally received (Taylor, 2008a; 
2008b; 2008c; 2008d).   
5.2.1.2 Engaging with Client in Local Setting 
Successful interventions were quick to engage with potential clients in a variety of ways, all in 
their own community, often times at their very own doorstep.  Many interventions sought local 
perspective and input in creating communication materials.  Various INGOs conducted PNAs, 
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client interviews, and held focus groups within the communities they intended to serve (Taylor, 
2008a; 2008b; 2008c; 2008d).  This was a brilliant strategy; using community-based 
participatory methods to engage with client stakeholders aided in collecting useful data on user 
preferences and obstacles to LARC provision (Rajani, 2006).   
Successful outreach initiatives focused on starting dialogue between trained health care 
providers and potentially interested clients.  In Kenya, FHI 360 hosted community awareness 
events by employing community outreach agents (e.g., CHWs, HEWs, CBRHAs) to engage with 
potential users (FHI, 2006).  In the ACQUIRE Project in Kenya and Ethiopia, community 
outreach was done on an interpersonal level to account for low literacy rates and potential low 
exposure to mass media among clients.  Grassroots mobilization meant engaging with faith-
based, women’s and men’s, and youth groups (Taylor, 2008c).  To account for literacy concerns, 
the ACQUIRE Project also made sure that radio shows and print IEC materials were available in 
both national and local languages (Taylor, 2008a; 2008b; 2008c; 2008d).   
Client preferences, traditions, and social norms were also considered and respected in the 
more effective interventions.  In Guinea, IEC materials included culturally appropriate images; 
the families depicted were seen in both traditional Muslim and modern dress, and only female 
health providers were pictured (The ACQUIRE Project/EngenderHealth, 2008).  Additionally, 
the slogan used in Guinea, “un contraceptive ideal pour espacer les naissances,” translated to “an 
ideal contraceptive for spacing births,” and aligned well with Guinea’s culture preference for 
large families, and the desire to space but not necessarily limit family size (Taylor, 2008b).   
Successful interventions used a variety of communication channels to disseminate key 
messages and maximized the likelihood of reaching more people.  Rural radio was the most 
popular channel of communication as it was the most widely used by target audiences (Duvall et 
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al., 2014; Escandon et al., 2006; Taylor, 2008a; 2008b; 2008c; 2008d).  Save the Children in 
Guinea was particularly innovative in its use of creative media channels (e.g., radio, song, 
folklore, and theater production) (FHI, 2008; 2010).   
5.2.1.3 Addressing LARC Provision Obstacles  
To address demand side obstacles to provision, behavior change communication dealt with 
dispelling myths and misperceptions, promoting LARC safety, efficacy, convenience, and 
benefits, and increasing male engagement and awareness around how and where to receive FP 
services (FHI, 2006; May et al., 2011; Rajani, 2006).  IEC promotional materials and educational 
outreach conducted by CHWs and HEWs in the field were explicitly meant to “bridge the gap” 
in knowledge and address social stigma that may keep women away from LARC (Blumenthal et 
al., 2013; The ACQUIRE Project/EngenderHealth, 2008).  The ACQUIRE Project hired on 
technical partners to specifically research, design, and implement a communication campaign to 
generate demand for the IUD (part of its Supply-Demand-Advocacy (SDA) program model) 
(Taylor 2008a; 2008b; 2008c; 2008d).   
In the ACQUIRE Project in Kenya, the communication campaign aimed specifically at 
dispelling myths and misperceptions was titled “Fahamu ukweli wa mamb” or “Know the truth 
about the IUD,” and featured images of users and providers promoting LARC methods (Taylor, 
2008c).  The choice of this title was deliberate; after conducting focus groups with potential 
clients, researchers found that messages from health providers and satisfied users would be the 
most influential in swaying opinion in favor of using an IUD (Rajani, 2006).  In Ethiopia, the 
chosen slogan for the mass media campaign was “reliable as my choice…reversible when I 
decide,” whereas in Uganda the final concept message was “find out the truth” (Taylor, 2008a; 
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2008d).  These messages were decided upon after lengthy pre-testing trials with selected focus 
groups consisting of male and female villagers around the targeted age group. 
Questions of access were addressed through creative service delivery approaches 
including: (1) introducing mobile clinic services; (2) expanding public sector clinics that 
provided LARC methods; and (3) hosting “event days” where LARC services could be provided 
in a time-efficient manner (Blumenthal et al., 2013; Duvall et al., 2014; May et al., 2011; 
Neukom et al., 2011).  Strengthening referral networks (e.g., via pamphlets, word of mouth, 
flyers posted in community settings) also made women more aware of where and when the most 
convenient services were available to them (Blumenthal et al., 2013; Duvall et al., 2014; FHI, 
2008; 2010; Rajani, 2006).   
To address supply side obstacles to provision, effective interventions focused on training 
providers in LARC insertion and removal procedures, FP counseling, and infection prevention 
techniques so that their own biases against the method were eliminated (Asnake et al., 2013; 
FHI, 2006; Taylor, 2008b).  Health infrastructure was improved through direct financial 
investments in improved facility equipment, supplies, and re-stocking of commodities, whether 
by grant funding or partnerships with national level supply chain networks (May et al., 2011; 
Rajani, 2006).  The ACQUIRE Project in Ethiopia placed importance on strengthening the 
capacity of preexisting health care networks within the countries by providing technical 
assistance and “whole-site” training to improve provider knowledge and skills (Taylor, 2008a).  
Advocacy, made visible to the public through mass media campaigns, sought to improve general 
political support and funding for FP programs (Taylor, 2008a; 2008c; 2008d).  INGOs were able 
to, in some instances, negotiate with major pharmaceutical firms for discounted products (or 
price guarantees) on devices, in attempts to stabilize supply and prevent stock-outs (Duvall et al., 
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2014; May et al., 2011).  To account for breaks in the supply chain, INGOs also used creative 
approaches to service delivery; they provided LARC services not only in static health clinic 
settings, but through mobile outreach services as well as interpersonal communication (i.e., 
“door-to-door” or “peer-to-peer”) referral systems to direct interested clients to nearby available 
FP services (Blumenthal et al., 2013; Duvall et al., 2014). 
5.2.2 Shared Intervention Weaknesses 
5.2.2.1 Reliance on Changing Streams of Donor Support  
All ten interventions received substantial funding from health INGOs (e.g., MSI, John Snow, 
Inc., Pathfinder International), national development agencies (e.g., USAID, KfW 
Entwicklungsbank) and in some cases, anonymous donors (Neukom et al., 2011).  Interventions 
procured their LARC devices from a range of sources that included INGOs (e.g., John Snow, 
Inc.), foreign government donors (e.g., USAID), and reduced price agreements with large 
pharmaceutical firms (e.g., Bayer) (Duvall et al., 2014; FHI, 2006; Subramanian et al., 2008).  
The ACQUIRE Project was able to directly procure the IUDs as part of the $150 million dollar 
contract with USAID (Taylor 2008a; 2008b; 2008c; 2008d).  MSI developed a unique system 
where the MSI clinics charged urban clients on a sliding fee scale, enabling some portion of the 
revenue to then fund the free mobile outreach services in more underserved rural areas (Duvall et 
al., 2014).  The IFHP found that maintaining a ready supply and flow of commodities was 
challenging; although they had originally agreed to the Ethiopian MoH providing commodities 
post-training, they often provided additional implant kits to HEWs as their original supply ran 
out (Asnake et al., 2011).   
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In every case, the funding was specified for a designated time period with the 
understanding that at project’s end, that money stream would be cut.  Any intervention must 
strongly consider how project operations will continue once the designated funding period has 
passed.  Within the ID field, there are countless stories of successful interventions ceasing to 
exist once the implementing agency has packed up its bags and withdrawn from project 
operations.  This is a grave consideration; ending LARC services in an area where they were 
once available means that clients may suffer health consequences if their device cannot be 
properly removed (and they use illegitimate or unsafe means to remove it).  In the case of FP 
services in the many poor countries of SSA, it is the hope that sustainable LARC provision will 
be shifted to public funding streams (e.g., national ministry of health budgetary spending) once 
the many short-term interventions conclude (Okonofua, 2014).  However, the viability of that 
shift in funding depends on political commitment, available discretionary funds (often a very big 
problem in poor, underdeveloped regions of the world where the ability to collect taxes is 
limited), and bureaucratic capacity at the top to manage such funds in an effective and honest 
manner (resisting the ever-present temptations of corruption and fungibility).   
5.2.2.2 Top-Down Program Governance 
Some implementing agencies did better than others when it came to considering the inclusion 
and integration of local health providers, local ownership, and the long-term involvement of 
national health programs during project implementation.  The question of who was responsible 
for training providers varied; while some more inclusive projects used native hospital staff and 
doctors to train mid-level health personnel (i.e., the idea of task shifting), the majority employed 
(presumably foreign) staff to directly train providers and CHWs (Asnake et al., 2012).  It should 
also be noted that all of the implementing agencies (with the exception of the Consortium of 
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Reproductive Health Associations [Ethiopia] and the Society for Women and Aids in Africa 
[Senegal]) are headquartered in either the United States or another highly developed European 
country (e.g., Germany, United Kingdom).  The relative lack of African run NGOs taking on a 
primary role in these interventions was disappointing, as more native involvement would be a 
welcomed sight.   
Many interventions worked in collaboration with the national MoH; while respectful of 
their policies, INGOs still brought with them outside technical assistance partners and foreign 
staff to lead clinical trainings, direct LARC procurement, and update FP medical guidelines 
(Subramanian et al., 2008; Taylor, 2008c) As an exception, the IFHP in Ethiopia did consult with 
national level medical schools and native medical professionals to help create training materials 
(Asnake & Tilahun, 2010).  This included hiring 72 native-born obstetricians and gynecologists 
to serve as “master trainers” during the HEW implant competency trainings.  Additionally, the 
ACQUIRE Project also deserves recognition for deliberately hiring native advertising firms in 
each country of operation, to create and test its creative concepts and key messages with focus 
group participants.  FHI 360 also consulted with the department of obstetrics and gynecology at a 
national university, in addition to national professional healthcare organizations when asking for 
recommendations in IUD revitalization efforts (FHI, 2006).   
Still, in the majority of cases, the high profile INGO stepped in and took charge of the 
intervention timeline, allowing minimal (almost superficial) control to pass to native-born 
institutions and individuals, which could have been very strong assets for overall project success.  
To be fair, many countries in SSA lack a cadre of highly skilled health personnel and proficient 
medical schools, and often suffer from brain drain (i.e., native-born students graduate with their 
professional degrees and immediately seek employment in other countries with higher wages and 
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better job opportunities).  In this regard, it may have been the case that INGOs would have 
preferred to employ and work with native-born health professionals and institutions, but were 
unable to do so because those options were limited in the country of operation.  Additionally, 
while it appeared that the national ministries of health were appreciative of INGO efforts, all of 
the available literature was published by the implementing agency, and it is difficult to say how 
the national leadership truly felt about the INGOs operating in their country or their ultimate 
level of involvement in the intervention.   
5.2.2.3 Missing Long-Term Sustainability Plan 
While most interventions were well-equipped to plan for project implementation, monitoring, 
and evaluation over the designated funding period, very few planned for the long-term 
sustainment of project achievements.  In many cases, implementing INGOs relied on handing 
over their tasks and responsibilities to health officials within the national MoH, who may or may 
not have been ready to assume the entire scope of program activities (Asnake et al., 2011; FHI, 
2006; Rajani, 2006; Taylor, 2008d).  The reviewed literature made very little note of this 
transition, and ultimate long-lasting success at any meaningful time point following the project 
remains unknown. 
In only one case did the implementing agency make note of a detailed strategy to provide 
LARC method removal services (Duvall et al., 2014).  MSI stressed the importance of having 
appropriate infrastructure in place to uphold client trust and loyalty when the time came to return 
for implant removal services  (Duvall et al., 2014).  Most interventions focused on training 
providers on LARC insertion and removal techniques, but did not provide further details on how 
these devices would be safely removed three to ten years down the road.  Those considerations 
seemed beyond the scope of the funding period and project implementation timeline, and as 
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such, received little mention in the reviewed literature.  Discussion around removal is key; 
LARC methods require a trained medical provider to safely retrieve the device after its 
effectiveness has diminished (Greifinger, 2015).  To provide LARC insertion services, but not 
have equally robust removal services in place is counter to the Hippocratic oath to “first do no 
harm.” 
To be fair, some interventions did implement strategies that focused on sustainability 
considerations once the INGO had packed up and headed home.  In Kenya, the ACQUIRE 
Project valued training native medical providers to train others in IUD insertion and removal 
skills to sustain confident service delivery after project’s end (Rajani, 2006).  Still, ACQUIRE 
staff acknowledged that the Kenyan MoH ultimately had ownership over the long-term success 
of the IUD revitalization effort, and ongoing support from policy makers, providers, and 
supervisors would largely determine long-term project success (Rajani, 2006).   
Unfortunately, all interventions reviewed were completed under very short timelines 
spanning just eight months to five years in length.  Although they might have seen positive 
results in that limited time frame, any robust documentation of sustainable desired outcomes is 
lacking.  One implementing INGO, FHI 360, stressed how further research, monitoring, and 
evaluation were needed to pinpoint best practices in LARC promotion in SSA (FHI, 2008).  In 
the Zambia case study, the intervention team, led by PSI, acknowledged that scaling up 
successful pilot programs to perform nationally had historically been difficult in SSA (Neukom 
et al., 2011). 
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5.3 OTHER CONSIDERATIONS  
5.3.1 Regional Factors Influencing Client Uptake 
Multiple research studies across SSA have examined factors that influence potential client uptake 
of LARC.  Factors relating to client knowledge and attitude include: (1) little awareness 
regarding these methods; (2) general misunderstanding of health risks and side effects associated 
with each method; and (3) lack of control over contraception when decisions are made primarily 
by male partner (Babalola, John, & Yinger, 2013; Williamson et al., 2009).  The following 
sections further elucidate research findings from Uganda, Nigeria, Ethiopia, Madagascar, and 
Kenya. 
In Uganda, research respondents all understood that LARC prevents pregnancy, and most 
were aware of how the devices were inserted (Anguzu et al., 2014).  They cited LARC side 
effects as the main reason for not choosing them, particularly a belief that they would cause 
permanent infertility.  They also felt that married women should not use LARC, because they 
should steer clear of contraception that could harm their ability to bear children.  Almost half of 
the women surveyed felt that their male partners should decide on which form of contraception 
to use (Anguzu et al., 2014).  In Zambia, one study also found that while the husband’s 
involvement in making joint decisions regarding contraception led to an increase in the use of 
LARC methods, the variable with the strongest association to LARC was the wealth index; those 
women in the wealthiest households were far more likely to use a LARC method than those from 
moderately wealthy to poor households (Mutombo & Bakibinga, 2014).   
In Nigeria, study participants also cited fears of side effects and infertility if a couple 
chooses to use FP early on in their reproductive years (Babalola & John, 2012).  Regarding 
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LARC, participants were aware of all of the methods but their knowledge was limited.  IUDs 
were the most well known LARC method; still, side effects and negative misperceptions were 
common (e.g., IUD makes you more likely to get an STI, and harms your male sex partner).  
Participants also stated their preference for making joint decisions regarding contraception, 
although the woman may act covertly if the husband opposes its use.  Important considerations 
when choosing a contraceptive method include its cost, ease of use, non-contraceptive benefits, 
and safety concerns (Babalola & John, 2012). 
In Ethiopia, among surveyed married men and women in northern Tigray, knowledge 
regarding LARC methods were described as superficial, meaning that study participants only 
knew the method names, but not much more (Gebremariam & Addissie, 2014a).  They in part 
attributed this to FP counselors who did not provide them with information on all methods, and 
focused on the injectable and pill.  With LARC, women were fearful of not being able to 
complete physical tasks after the insertion or removal procedure.  There was also a mistrust of 
FP workers to perform the procedures safely, and concern over the pelvic exam required for 
IUD/LNG-IUS (Gebremariam & Addissie, 2014a).  Intention to use a LARC method was low, 
and the main reasons again were fear of side effects and infertility.  A higher level of education 
and a smaller ideal family size (and desire to delay childbearing for next two years) factored 
positively into the women’s stated interest in a LARC method (Gebremariam& Addissie, 2014b).  
Interestingly, another study among married women in western Ethiopia found that women who 
made joint fertility-related decisions with their male partners were six times more likely to use 
LARC, and those who had a prior discussion with a FP counselor about LARC methods were 14 
times more likely to use LARC (Melka, Tekelab, & Wirtu, 2015).  Another positively associated 
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factor included having a television or radio, thus increasing the client’s exposure to LARC 
messaging (Melka et al., 2015).   
In Madagascar, a qualitative study with women who were considering the IUD revealed 
the staged decision-making steps that were made alongside varying levels of social support.  
Researchers identified the following stages: “Stage 1: perceived benefits of the IUD countered 
by initial fear; Stage 2: lingering fear of the IUD; [and] Stage 3: perceived ability to go to the 
clinic to receive the IUD” (Gottert, Jacquin, Rahaivondrafahitra, Moracco, & Maman, 2015, p.  
291-293).  During stage 1, women were aware of the benefits that an IUD provides for 
contraception, but were still afraid of having the device inside of them and the associated health 
risks.  Upon hearing these fears and misperceptions, FP counselors were often able to step in and 
correct the misinformation.  However, during stage 2, the assistance of a health provider was not 
sufficient for many to truly consider the IUD, and women desired to hear independent advice 
from other IUD users they knew in their community.  Once this occurred, women felt more 
comfortable and confident in proceeding to a clinic to receive the device (stage 3) (Gottert et al., 
2015).   
 In Kenya, research participants were given the option of choosing from a variety of 
contraceptive methods and then asked why they decided on LARC methods.  The implant was 
the most popular (at 30 percent), while the LNG-IUS (16 percent) and copper IUD (2.5 percent) 
were chosen far less frequently (Hubacher, Masaba, Manduku, & Veena, 2013).  Women 
preferred the implant because they believed it was less painful to insert and remove, had fewer 
side effects, did not involve an invasive pelvic exam, and could not fall out or move in the 
abdomen as they believed the other methods could.  The most commonly cited reasons for not 
choosing the LNG-IUS were fear of pain or discomfort, hormonal side effects, and modesty 
  70 
around the insertion procedure.  Still, women preferred the LNG IUS to the copper IUD 
primarily because of their preference for a five-year duration of action over the ten-year duration 
of action (although this shows they were unaware that the copper IUD could be removed at any 
time), in addition to belief of fewer side effects and lighter menstrual bleeding (Hubacher et al., 
2013).   
5.3.2 International Commitment 
For the past two decades, international aid money has been earmarked for other public health 
initiatives within SSA that focus on more urgent concerns such as the HIV/AIDS epidemic, 
battling tuberculosis, and malaria (Jacobstein et al., 2009; Mbizvo & Phillips, 2014).  FP 
programs were generally underfunded and thought to be of less immediate importance.  The 
1994 International Conference on Population and Development (ICPD) was a remarkable 
moment for SRH rights; it was at this conference that women’s rights, gender equality, and 
universal access to reproductive health were recognized as key components to development 
(UNFPA, 2008).  In 2007, following the Millennium Summit held in 2000, achieving universal 
access to reproductive health was added to Millennium Development Goal (MDG) 5, which 
focused on reducing the maternal mortality ratio (MMR) by 75 percent between 1990 and 2015 
(Patel, 2014).  A key indicator for measuring global MMR reduction (target 5A) was the 
proportion of deliveries attended by skilled health personnel.  Other health indicators were 
chosen to measure progress in achieving universal access to reproductive health (target 5B), 
including the contraceptive prevalence rate, adolescent birth rate, and antenatal care coverage. 
However, progress in reaching this MDG sub-target has been limited.  Despite promising 
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international momentum, contraception for many national governments remains a controversial 
topic for discussion at the international level.   
Women in SSA cannot afford to wait for stalled public health commitments to FP and 
SRH services.  Given current population growth projections in the region, FP services must 
expand by an estimated 50 percent from 2005 levels to maintain the current mC prevalence rate 
in the year 2020 (Jacobstein et al., 2009).  This essentially means, “programs will have to run 
much faster just to remain in the same place” (Jacobstein et al., 2009, p.  150), with no 
improvements made in increasing low mC use or decreasing high unmet need. 
The 2012 London Summit on Family Planning set forth an ambitious goal of enabling 
120 million more women in the developing world to gain access to FP services by 2020 
(Peterson, Darmstadt, & Bongaarts, 2013).  One outcome of the summit was the initiative Family 
Planning (FP) 2020, described as a “global partnership that supports the rights of women and 
girls to decide freely and for themselves whether, when, and how many children they want to 
have” (Family Planning, 2015a).  FP 2020 is promoted by the United Nations Foundation and 
tied directly to Sustainable Development Goals (SDGs) 3 and 5, which call for universal access 
to SRH services and rights by 2030 (Okonofua, 2014).  Global commitment to FP 2020 goals is 
crucial to improving prospects for FP services in the developing world. 
Support for FP 2020 comes from the International Youth Alliance for Family Planning 
(IYAFP), International Federation of Gynecology and Obstetrics (FIGO), International Planned 
Parenthood Federation (IPPF), and the International Confederation of Midwives (ICM) in 
addition to major ID players such as USAID and the Bill & Melinda Gates Foundation (Family 
Planning 2020, 2015b).  FP 2020 recently released a statement in 2015 entitled Global 
Consensus Statement for Expanding Contraceptive Choice for Adolescent and Youth to Include 
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Long-Acting Reversible Contraception.  It promotes improving access to LARC for all sexually 
active youth, and ensuring LARC methods are included in a balanced mC method mix during FP 
consultation (FP2020, 2015a).  Thirty least developed countries (LDCs) have signed on to the FP 
2020 initiative, together with big donors pledging more than $4.6 billion in future funding (Fabic 
et al., 2015).  While involved INGOs and state actors have publically pledged support and 
political commitment, the initiative lacks real enforcement or meaningful accountability 
standards to hold its members responsible for completing any agreed upon tasks. This may prove 
to be the largest obstacle in achieving the goals set at the 2012 London Summit. 
Friday Okonofua, Editor of the African Journal of Reproductive Health, believes that 
while recent international attention towards FP and SRH services in SSA is a good start, national 
governments must now take the lead through further political commitment to implementing the 
SDGs.  As he states, “most African governments have shown poor commitment to [FP] services 
over the past two decades…[due to] internal conflict and beliefs about [FP], and…limited 
prioritization of health and social development issues” (Okonofua, 2014, p.  10).   
5.3.3 Cost-Benefit Analysis  
The cost-savings related to mC use are impressive.  One study calculated that for every $1,000 
spent on FP and mC, $3,700 is saved over a ten-year period due to reductions in associated costs 
for obstetric care, childhood immunization, and primary school enrollment (Cleland & 
Machiyama, 2015).  Countries that invest in mC save $1.40 in MCH services for every $1.00 
spent (Mbizvo & Phillips, 2014). 
LARC methods are commonly underutilized due to their high initial cost at insertion, in 
addition to the need for specialized equipment, sterile materials, and more time for provider-
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client counseling and interaction (May et al, 2011; Neukom et al., 2011).  However, LARC has 
proven to be the most cost-effective mC method when considering duration of use, efficacy, and 
long-term user savings (Doyle et al., 2008; Blumenthal et al., 2011; Mbizvo & Phillips, 2014).  
Even when not used for its full duration, LARC becomes cost-saving within three years of use, 
compared to short-acting reversible methods (Trussell, Hassan, Lowin, Law, & Filonenko, 
2015).  In one US study, LARC saved $7.00 in costs of unintended pregnancy for every $1.00 
spent (Tsui et al., 2010).   
Although the IUD has a high initial cost at insertion, once the device is used for two or 
more years it becomes more economical than other short-term methods (e.g., oral contraceptives, 
injectables) that require the user to return for multiple resupply visits (Rajani, 2006).  In fact, the 
IUD is the least costly reversible form of mC on the market today, at just $0.58 for average 
annual direct costs per user (Singh et al., 2014).   
In 2008, on average, contraceptive progestin implants cost $27.00 each (Hubacher et al., 
2008).  However, in 2013, the manufacturers of Jadelle and Implanon through agreements with 
international partners agreed to drop the price to $8.50 per unit for all countries in SSA with 
maternal mortality rates greater than 100 to 150 per 100,000 live births (Reproductive Health 
Supplies Coalition, 2013).  The manufacturer of Sino-Implant II, an implant similar to Jadelle, 
has also recently sold the unit in developing countries for one-third the cost of other implants 
(Greene & Stanback, 2012).  These public-private partnerships result in price-volume guarantees 
that have made implants more widely accessible and cost-competitive (Duvall et al., 2014) 
While the cost of providing LARC may be substantial at onset, the savings from 
estimated pregnancies that are averted are overwhelmingly larger.  Annual household 
expenditures for contraceptive can account for 5 percent up to 20 percent of annual income in 
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SSA (Blumenthal et al., 2011).  Many health INGOs provide low cost FP services to SSA 
women who cannot afford them by providing vouchers and heavily subsidized FP services to 
clients; interventions funded by USAID often procure LARC directly through price negotiations 
with pharmaceutical companies, which frequently make large-scale cost reductions or donations.   
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6.0  CONCLUSION 
FP services allow women to choose the size and timing of their family, and lessen the burden of 
unintended pregnancy.  Access to such services has a tremendous positive impact on the health 
of mother and child, educational attainment, poverty alleviation, and female empowerment in the 
developing world.  LARC methods are a new way forward in the discussion of mC in SSA, 
where women rely primarily on short-acting reversible contraception that is more likely to fail.   
Twenty articles, covering ten interventions in 16 SSA countries met selection criteria for 
this paper.  Various obstacles to effective LARC provision exist in SSA.  Substantial supply side 
barriers (i.e., provider bias, failing health infrastructure, weak political support, poor funding, 
and breaks in the supply chain), and significant demand side barriers (i.e., myths and 
misperceptions, little knowledge, limited access to services, and social stigma) for policy makers, 
providers, and clients abound.  Shared intervention strengths include engaging with key 
stakeholders and clients in their own communities, as well as appropriately addressing obstacles 
to effective LARC provision.  Shared intervention weaknesses include heavy reliance on donor 
funding, top-down program governance, and a missing long-term sustainability plan.  Regional 
factors influencing client uptake, international commitment to LARC, and a cost-benefit analysis 
of mC methods are also important considerations.  This final chapter concludes with 
recommendations for future SRH and FP interventions, paper limitations, and the overall public 
health significance of LARC promotion in FP programs for SSA. 
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6.1 RECOMMENDATIONS FOR FUTURE INTERVENTIONS 
Five major recommendations for international development practitioners were formulated by 
analyzing effective interventions. Recommendations are summarized in Table 2. 
 
Table 2: Summary of Recommendations 
1. Decentralization 
of Health Care 
Networks 
• Adopt the practice of task shifting (i.e., train lower-level 
providers to insert and remove the IUD and implant). 
• Improve access to FP services at the local level through creative 
service delivery mechanisms (e.g., mobile clinics, community 
referral agents). 
• Create public-private partnerships for LARC services (e.g, 
price-volume guarantees for LARC procurement). 
2. Capacity Building • Improve LARC service delivery through strengthened clinical 
provider training. 
• Integrate LARC procurement into national supply chain 
systems. 
• Include LARC in other MCH and SRH services (e.g., 
HIV/AIDS, STIs, postpartum care). 
3. Advocacy and 
Education 
• Create supportive policy environment at the regional and 
national level to ameliorate supply side barriers. 
• Focus educational outreach on male partners and spouses, 
stressing importance of joint decision-making for mC. 
• Educate clinical providers to eliminate provider bias. 
4. LARC 
Champions 
• Recruit passionate providers and satisfied users to promote 
LARC in community and increase demand for services. 
• Engage LARC champions in advocacy work at regional and 
national levels. 
• Ensure client-provider interaction is high quality.  
5. Community 
Awareness 
• Use social and behavioral change communication (SBCC) to 
improve community awareness. 
• Use community-based approaches (e.g., interpersonal 
communication) with CHWs and BCC agents in rural settings. 
• Use variety of communication channels (e.g., radio, billboards), 
and culturally sensitive messages and imagery. 
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6.1.1 Decentralization of Health Care Networks 
The first recommendation related to decentralizing health care networks is to adopt the practice 
of “task shifting.” Task shifting is used to increase community level health care access, and is an 
innovative response to the shortage and uneven distribution of qualified medical providers in 
much of SSA (WHO, 2013).  The policy means that mid-level medical providers (e.g., nurses, 
midwives) who do not have the competencies for specific tasks are trained for certain procedures 
that higher-level providers (e.g., doctors) typically perform (Babalola & Yinger, 2013; 
Greifinger, 2015).  Task shifting has had previous success with public health interventions 
addressing the management of childhood illness and injectable contraceptive service delivery 
(Asnake et al., 2012).  In fact, many countries already allow low- and mid-level health personnel 
to deliver a range of contraceptive methods (WHO, 2013).  One study published in the journal 
Reproductive Health found that employing task shifting for LARC provision is both a safe and 
effective way to increase mC use (Polus et al., 2015).   
The WHO recommends that nurses, midwives, and auxiliary nurse midwives (but not 
CHWS or CBRHAs) be able to insert and remove implants and IUDs following competency-
based trainings (Mbizvo & Phillips, 2014; WHO, 2013).  MSI already employs task shifting in 
its FP services globally (Duvall et al., 2014).  Pathfinder International also employed task 
shifting in Ethiopia to train HEWs on implant insertion and removal at their village-level health 
posts (Asnake et al., 2011).  While task shifting permits lower-level health providers to perform a 
procedure or duty normally “off limits” to them, the strategy does not compromise the medical 
fundamentals of care (Pile et al., 2007). 
The second recommendation related to decentralization is to improve access to FP 
services at a more local level.  Geographical barriers to access frequently prevent women from 
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reaching LARC services when they desire to do so (Cleland, 2009).  INGOs cannot solely rely 
on static health facilities, often located in urban or semi-urban areas, for distributing LARC; 
mobile clinics, community referral agents, and other forms of community-based provision are 
innovative approaches to better reaching the client.  Women living in rural areas are often 
restricted in their mobility due to little transportation and exorbitant costs to travel to urban areas 
where FP clinics are located.  Expanding FP services by dispatching mobile clinics and outreach 
agents to rural areas further improves access, as the number of trained health personnel in these 
settings is severely lacking (Asnake & Tilahun, 2010; FHI, 2007; Taylor, 2008a).  MSI is just 
one INGO that uses a network of interrelated service delivery channels to reach women located 
in different and remote geographical areas (Duvall et al., 2014). 
When it comes to these two recommendations (i.e., task shifting and improving access to 
services), the creation of public-private partnerships for LARC services is an important factor for 
success.  Private sector provision (e.g., privately run clinics, hospitals, pharmacies, and NGO 
facilities) differs from public sector provision (e.g., government run clinics, hospitals, and public 
health workers) for FP services (Ugaz, Chatterji, Gribble, & Mitchell, 2015, p.  E4).  In SSA, one 
survey of married women ages 15 to 29 in 18 countries showed the great majority of mC is 
obtained through public provision (72 percent) (Ugaz, et al., 2015).  Indeed, the majority of FP 
services in SSA are provided by the public sector that offers a very limited range of mC, 
generally focused on promoting short-acting reversible methods (Mbizvo & Phillips, 2014).  
When one or two methods are overwhelmingly used in a country, the mC method mix is skewed.  
Method skew may reflect cultural and social norms, or more concerning factors including 
government population policies, lack of access, and provider bias (Sullivan et al., 2006).  It has 
been shown that the more mC methods available, the greater the likelihood of their use (Pile et 
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al., 2007).  Engaging the private sector to provide LARC services can expand the mC method 
mix available to women who can afford to pay for these services (FHI, 2007).  The WHO and 
UNFPA both recommend that the public and private sectors collaborate and coordinate their 
service delivery approaches to provide greater access to FP services for urban and rural clients 
alike (UNFPA, 2008; WHO, 2012).   
While decentralizing health care networks brings services closer to the people, efforts 
must be made to ensure that national level commitment to LARC method expansion is met with 
local level commitment and enthusiasm (UNFPA, 2008).  As was the case in Uganda, national 
health policy was centralized, but budgetary decisions and service delivery coordination were 
managed at the district and village level; this led to a frustrating lack of coordination 
(Subramanian, 2008).  In Guinea, the pronatalist policies of a military regime that had held 
power for decades left an intractable mark on efforts to provide comprehensive FP services to 
Guinean families, who were actively pressured to have many children (Escandon et al., 2006).  
Only when the government changed hands, with a new leader who understood the importance of 
providing FP services, did the situation on the ground slowly start to improve.  These examples 
underscore the importance of political support when implementing FP programs that focus on 
LARC provision in SSA. 
6.1.2 Capacity Building 
The first recommendation related to capacity building is to improve LARC service delivery 
through strengthened provider training.  The WHO recommends routine training, support, and 
supervision for insertion and removal techniques, in addition to continued monitoring and 
evaluation measures (WHO, 2012).  FP providers commonly stated that their relative 
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inexperience with proper insertion, removal, and sterile procedure biased them against promoting 
LARC.  Providers must be trained in proper insertion and removal procedures; in fact, most 
infections can be attributed to the time of insertion and are preventable with the proper measures 
(e.g., antiseptic insertion and infection prevention techniques)  (Doyle et al., 2008).  Training in 
pre-insertion counseling is also important, as providing potential clients with information 
regarding the LARC device can help them better tolerate known side effects when and if they 
experience them following insertion.  As Ladipo and Akinso (2005) state, “counseling and 
education remain powerful tools in overcoming barriers to poverty, illiteracy, and conservative 
social customs” (p.  21).  FP programs must also guarantee that women can access same-day, 
low cost removal services, which means that the necessary removal supplies and referral systems 
for women who accessed services through mobile outreach must be strengthened (RHSC, 2013).  
MSI was one such INGO that focused heavily on the strengthening of implant removal services 
in its regional work (Duvall et al., 2014).   
The second recommendation for capacity building calls for greater integration of LARC 
devices and services into national supply chain systems and other MCH service provision.  
Effective FP interventions should ensure that LARC devices are integrated into nationally 
maintained commodity logistics systems that account for the devices in national budgetary 
spending, thereby eliminating reliance on donor funding (Ladipo & Akinso, 2005).  Ensuring 
LARC provision through a reliable supply chain means that women have a greater degree of 
security when it comes to meeting their demand for FP services.  MSI recommends that INGOs 
collaborate with national governments to ensure that LARC devices and equipment are supplied 
in a steady and reliable fashion (May et al., 2011).  FHI 360 proposes that LARC methods should 
be included on lists of essential drugs, which can further improve availability.  In fact, the WHO 
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publishes a World Health Organization Model List of Essential Medicines, and added two 
implants to the list in 2007, considering them among the most essential drugs in a basic 
healthcare setting (FHI, 2007).  Often, medical clinics lack the requisite surgical materials for 
LARC insertion or removal because they have not been included on a list of essential supplies 
(Mbizvo & Phillips, 2014).   
Integration of LARC service provision into other MCH and SRH discussions around 
HIV/AIDS, STIs, HPV, postpartum and postabortion care is also seen as a promising practice 
recommended by the WHO (Jacobstein et al., 2009; Mbizvo & Phillips, 2014; WHO, 2012).  
Clinical providers and community health workers should be encouraged to speak with clients 
around mC and LARC methods in other health settings where the discussion may not have been 
previously considered (e.g., STI/HIV screening clinic, prenatal care consultation, postpartum 
check up).  As more international development health policies (e.g., the United Nation’s MDGs 
and SDGs) support women giving birth with skilled birth attendants in health facilities, there is 
an increased opportunity for postpartum insertion of an intrauterine contraceptive device 
(PPIUCD) that has had promising results in various developing countries (MCHIP, 2013). 
6.1.3 Advocacy and Education  
Advocacy entails the creation of a supportive policy environment regarding LARC and FP 
policies at the regional and national level.  Both international development practitioners and 
community “LARC champions” should conduct advocacy within the country (see 
recommendation 4).  Engaging in advocacy is important when seeking redress for supply side 
obstacles to effective LARC provision, including failing health infrastructure, poor or 
nonexistent funding streams, and breaks in the supply chain.  Advocacy should target not only 
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national policy makers who pass budgets and bills, but also providers and clients, to develop a 
strong base or constituency of support.  Widespread stakeholder participation can be developed 
through advocacy that targets important local and national civil society groups, as well as 
nontraditional leaders (e.g., youth groups, men’s and women’s groups, faith-based organizations) 
(UNFPA, 2008).   
To address funding concerns, advocates should stress the importance of LARC in other 
MCH and SRH fields, in addition to its role in national economic development (through 
permitting female economic participation and higher worker productivity).  To address the social 
stigmas surrounding FP, advocates should play up the non-contraceptive benefits of using LARC 
with more conservative policy makers (see Appendix B). Advocates in countries with pronatalist 
policies should encourage policy makers to view LARC as vital for safe spacing intervals, and 
therefore improving overall maternal and child health outcomes. FHI 360 proposes that advocacy 
efforts focus on encouraging national health ministries to update and improve existing FP 
policies, medical guidelines, and protocols to reduce barriers to access (FHI, 2007).  
Interestingly, the ACQUIRE Project in Uganda had not originally thought advocacy to be a 
primary focus; however, it noted that as the IUD revitalization intervention began it became an 
essential component of the program (Subramanian et al., 2008).  
Education should be approached as an ongoing conversation or exchange with clients, 
rather than a one-directional process (Greifinger, 2015).  Effective education focuses on 
correcting demand side barriers to LARC provision; that is to say, myths and misperceptions 
over health concerns, little knowledge or access, and social stigma.  Education should include 
targeted outreach for male partners, who are often the sole decision-makers in patriarchal 
households (Babalola et al., 2013; Babalola & Yinger, 2013).  Frequently, FP interventions focus 
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on serving the woman to the detriment of men’s inclusion in the process (OlaOlorun & Tsui, 
2010).  With male support, women will not be forced to rely on traditional methods of 
contraception or to seek mC using covert measures.  Men need to be made aware of their 
important role in joint decision-making regarding fertility preferences, and efforts should seek to 
increase their understanding and alter any negative perceptions around male involvement in FP.  
The WHO recommends reaching men and women in their communities through CHWs and 
targeted promotional communication campaigns (WHO, 2012).   
Education must also target clinical providers; provider bias is a larger obstacle than many 
may believe.  Often it is the provider who has misinformation regarding contraception (e.g., 
IUDs spread STIs, can only be inserted during certain time in menstrual cycle, are off limits for 
women who are breastfeeding) that is then passed on to the client.  Provider bias includes 
reluctance to suggest LARC because of its time intensive nature for insertion and removal 
(compared to short-acting reversible methods), in addition to low confidence in performing the 
insertion safely  (Greifinger, 2015; Rajani, 2006).  Moral and religious objections also prejudice 
provider decisions against offering LARC (Babalola & Yinger, 2013; Goldstruck, 2014).  Most 
of these aspects of provider bias can be corrected with evidence-based education.  Additionally, 
mC is most frequently discontinued due to side effects or health concerns experienced by the 
user (Doyle et al., 2008; Cleland & Machiyama, 2015).  If providers can be taught to effectively 
address this during client-provider counseling, users will be better prepared to handle potential 
side effects, which generally last for only the first three to six months following insertion. 
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6.1.4 LARC Champions 
Creating demand for LARC services must be considered as important an investment as 
increasing access to LARC services (Cleland & Machiyama, 2015).  Globally, almost 20 percent 
of married women who use mC choose the IUD (Bluestone et al., 2006).  In absolute value, it is 
the most commonly used reversible contraception method worldwide.  However, demand for the 
IUD is highly concentrated in certain parts of the world (e.g., Europe, Asia), and basically 
excludes most of SSA.  The same can be said of the contraceptive implant, which has been slow 
to gain traction in SSA.  To improve visibility and demand for these services, passionate 
providers and satisfied users can promote LARC by emphasizing its effectiveness, safety record, 
and relatively minor side effects to clients, fellow medical professionals, and larger mass media 
outlets.  These passionate providers and satisfied users will be “LARC champions,” visibly 
promoting the method at work and in their communities to spark interest and discussion around 
its use. Additionally, LARC champions can serve as policy advocates at the regional and national 
levels, lobbying for support of advantageous national health policies that promote FP services 
and providing LARC methods. 
Satisfied LARC users can champion the method by speaking with potentially interested 
clients at local level community outreach events (Gottert et al., 2015).  The ACQUIRE Project in 
Ethiopia employed satisfied user testimonials on radio talk shows, allowing interested clients to 
call in and ask questions in a shared yet informal setting (Taylor, 2008a).  Such testimonials do 
not necessarily require a modern communication channel; effective interpersonal communication 
with satisfied users and outreach agents (e.g., CHWs, CBRHAS) may be even more effective in 
rural settings where literacy and exposure to mass media is low.  As formative research 
conducted by MSI indicated, women valued the advice and feedback of their peers when making 
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fertility-based decisions, and found the most influential source of information to be peers who 
had previously used MSI services (Duvall et al., 2014).  A policy brief out of Malawi stresses 
that successful FP programs should employ local men and women who are familiar with or 
currently using LARC methods to talk about it with prospective clients, particularly focusing on 
why they chose it and the benefits they have received from it (Babalola et al., 2013).  Health 
INGOs should also actively recruit respected individuals and influential civil society 
organizations to become visible LARC champions in mass media communication campaigns 
(Jacobstein et al., 2009).   
It is also important, on the discussion of LARC champions, that the interaction between 
client and provider is high quality, meaning that the client is well-informed, the provider is 
skilled and passionate about LARC, and the service site is well supplied and managed (Pile et al., 
2007).  Passionate LARC providers who have a good reputation in the eyes of their clients are 
destined for greater success than those who begrudgingly accept to provide LARC services.  For 
effective providers, “commitment, attitude, and work ethic are as important as clinical skills” 
(Neukom et al., 2011, p.  451). 
6.1.5 Community Awareness 
For FP programs that seek to introduce LARC, minimal client knowledge regarding mC and how 
to access it, as well as initial social resistance to mC are major barriers to project success 
(Cleland & Machiyama, 2015).  Community awareness can be improved through social and 
behavior change communication  (SBCC) that spreads thoughtful FP messages through a variety 
of channels (e.g., print, television, radio, community outreach).  SBCC has been effective in 
changing general attitudes and increasing knowledge of FP even among populations with low 
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literacy (Melngailis & Eber, 2006; Jacobstein et al., 2009).  Effective SBCC targets both the 
primary audience (e.g., potential users) in addition to secondary audience members (e.g., policy 
makers, providers, spouses, males).  Mass media campaigns that also engage with local religious 
and traditional leaders improve the social acceptability of mC use (Cleland & Machiyama, 
2015).  In rural settings, community-based approaches (e.g., interpersonal communication with 
peer educators, trained BCC agents and CHWs) that address demand side obstacles and potential 
health concerns are most effective (FHI, 2007; Mbizvo & Phillips, 2014).  These approaches are 
strong because CHWs and BCC agents who are recruited from the community share a common 
language and customs with their clients, and are viewed as trusted sources of information 
(Cleland, 2009).   
Effective SBCC should consider the FP needs of women and their short- and long-term 
considerations (e.g., user preference between initial costs versus length of protection).  The 
overall objective should be to normalize the discussion around sex, particularly women seeking 
protection from pregnancy and STIs, and make it more acceptable for youth and nulliparous 
women in SSA to want to delay childbearing.  Creative concepts and key messages should be 
given careful thought by first conducting formative research via focus groups and qualitative 
interviews in which possible themes can be pre-tested with an audience before diffusion 
(Melngailis & Eber, 2006).  Messaging should be mindful of cultural preferences and gender 
norms, and skillfully address negative public sentiment around couples that choose to have 
smaller families than social norms may allow (Babalola et al., 2013).   
Effective interventions used a variety of communication channels and culturally sensitive 
imagery that considered dress, language, religion, and customary practices (Blumenthal et al., 
2013; FHI, 2008; Rajani, 2006; Taylor, 2008b).  With multiple channels, there is a greater 
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likelihood of reaching a larger geographical area and more potential clients that may not have 
access to mainstream media (Duvall et al., 2014).  Channel selection was often dependent on the 
most widely used media form (typically radio) and literacy rates of the population.  Indeed, 
among adolescents in SSA, most report hearing about FP services through radio, television, and 
the newspaper, with a smaller percentage reporting actually visits to clinics or by CHWs 
(McCurdy et al., 2014).  The use of cellphones as a communication channel should also be 
considered; telemedicine is an exciting new development that shows promise in connecting 
people to needed health care services in remote settings.  
Evaluation methods conducted by INGOs during project implementation demonstrated 
that they too could have improved community awareness in a number of ways.  For one, the 
IFHP in Ethiopia stated that more attention should be paid to providing IEC materials in local 
languages, in addition to the national language (Asnake & Tilahun, 2010).  The ACQUIRE 
Project in Uganda also stated that its own demand creation activities should have used a wider 
range of communication channels and featured satisfied user testimonial at outreach events to 
improve reach and visibility (Taylor, 2008d).   
6.2 LIMITATIONS 
One limitation of this paper is that it is a literature review, and therefore added no original data to 
the existing literature on FP programs that provide LARC.  It includes only published articles 
from peer-reviewed journals and website document databases that are in the English language.  
This may be problematic due to the fact that SSA is comprised of countries that speak many 
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different languages (e.g., Arabic, Swahili, Yoruba, and French), and thus potentially limits the 
inclusion of original research completed in the region. 
Additionally, for many of the interventions studied, the only available literature 
reviewing the methods of service delivery and behavioral change communication was published 
and/or funded by the implementing agency.  This may introduce a form of reporting bias, if in 
fact the intervention resulted in negative consequences or did not achieve the desired objectives.  
Large health INGOs have a strong desire to keep up appearances and preserve their reputation in 
the field of FP and SRH.  There is potential for the published results to be purposefully skewed 
or misrepresented, and for a report to show its organization in the best light possible by 
underplaying or ignoring any negative findings.  In other terms, INGOs are frequently criticized 
for their lack of transparency and accountability in setting program objectives early on in the 
intervention timeline, and later having no one to hold them responsible if they do not meet them.   
6.3 PUBLIC HEALTH SIGNIFICANCE  
In 2014, mC use by 652 million women worldwide prevented 231 million unintended 
pregnancies, and an estimated 1.1 million neonatal deaths and 100,000 maternal deaths (Singh et 
al., 2014).  If the 225 million women who presently have an unmet need for mC were able to 
access it, an additional 52 million unintended pregnancies, 500,000 neonatal deaths, and 70,000 
maternal deaths could be averted annually (Singh et al., 2014).  Regions of the world with the 
greatest unmet need, including SSA, would see the largest gains in MCH indicators (Singh & 
Darroch, 2012).   
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For women in SSA, combined oral contraceptives and injectables dominate the mC 
method mix available to them (Cleland & Machiyama, 2015; Cleland & Shah, 2013).  In fact, 
short-acting reversible methods account for 70 percent of the mC method mix, while LARC 
comprises less than 4 percent (Hubacher et al., 2011).  Generally, women who desire to space out 
or postpone childbearing gravitate towards short-acting reversible methods, while those who 
want to stop having children altogether side for LARC.  It is wrong to assume that women who 
want to space out or postpone births cannot use LARC; in fact, LARC is recommended for both 
women interested in postponing and those interested in stopping childbearing (Singh et al., 2014) 
Women who choose LARC do not have to worry about strict adherence or repeated use at 
each intercourse.  LARC has far lower typical and perfect use failure rates, and far higher 
continuation rates, when compared with short-acting methods (ACOG, 2011).  In simplistic 
terms, with LARC you can “set it and forget it” until the appropriate time comes for removal.  
One study found that if 20 percent of the roughly 18 million women in SSA who currently use 
oral contraceptives or injectables were switched to the implant for longer-term protection, 1.8 
million unintended pregnancies could be prevented over five years’ time (Hubacher et al., 2011).  
Additionally, the provision of LARC within FP services in SSA could prevent more than 70,000 
maternal deaths, keeping more than 250,000 children from becoming orphans annually 
(Jacobstein et al., 2009). 
Family planning saves lives.  There are obvious health benefits for the woman, as well as 
indirect benefits to her children, family, and society at large when she is able to access FP 
services.  A balanced mC method mix ensures that individuals can make the best choice given 
their unique medical needs and fertility preferences.  In SSA, commitment to expanding the mC 
method mix by including LARC is vital to achieving universal access to FP services. 
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APPENDIX B: TYPES OF LONG-ACTING REVERSIBLE CONTRACEPTION 
 Copper IUD LNG-IUS 
 
Contraceptive Implant 
 
Mechanism of 
Action 
-Spermicidal effect  
 
-Inhibits sperm migration to 
egg 
-Spermicidal effect 
 
-Inhibits sperm migration to 
egg 
 
-Thickens cervical mucus 
-Thickens cervical mucus 
 
-Suppresses ovulation 
 
-Alters endometrium lining 
Failure Rate 0.2% 0.3% 0.1% 
Effective 
Duration  
10 year FDA approval 5 year FDA approval 3 year FDA approval 
 
Insertion and 
Removal 
Process 
-Trained provider will insert 
IUD with help of speculum, 
tube slider through vaginal 
opening and cervix, into 
uterus 
 
-Removed by provider by 
grabbing IUD strings 
(hanging out of cervix) with 
forceps and slowly pulling it 
through cervix and out 
vaginal opening 
-Trained provider will insert 
LNG-IUS with help of 
speculum, tube slider 
through vaginal opening and 
cervix, into uterus 
 
-Removed by provider by 
grabbing LNG-IUS strings 
(hanging out of cervix) with 
forceps and slowly pulling it 
through cervix and out 
vaginal opening 
-Trained provider will 
perform transdermal 
insertion with preloaded 
applicator into upper arm 
 
-Removal requires minor 
surgical procedure by scalpel 
cut made in upper arm after 
feeling for implant’s location 
Insertion Period -Any time in menstrual cycle 
 
-Postpartum and postabortion 
-Any time in menstrual cycle 
 
-Postpartum and postabortion 
-Any time in menstrual cycle 
 
-Postpartum and postabortion 
Common Side 
Effects 
-Heavier bleeding during 
menses 
 
-Dysmenorrhea 
(painful menses) 
 
-Potential for expulsion or 
perforation of uterus 
 
-Change in bleeding patterns 
(frequency, amount, 
duration) 
 
-Less common side effects: 
weight gain, headaches, 
abdominal pain, acne, 
dizziness, nausea, breast 
tenderness, mood changes 
-Change in bleeding patterns 
(frequency, amount, 
duration) 
 
-Less common side effects: 
weight gain, headaches, 
abdominal pain, acne, 
dizziness, nausea, breast 
tenderness, mood changes 
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Sources consulted:  
Blumenthal et al., 2011; Espey & Ogburn, 2011; RHSC, 2013; WHO, 2015a; WHO, 2015b. 
 
-Potential for expulsion or 
perforation of uterus 
 
 
-Potential for difficulty in 
removal following implant 
migration 
Non-
Contraceptive 
Benefits 
-No hormonal side effects 
-Can be used as emergency 
contraception 
-Protective effect against 
endometrial cancer 
-Improves dysmenorrhea  
(painful menses) 
-Increases hemoglobin 
-Prevents anemia 
-Treats menorrhagia (heavy 
vaginal bleeding) 
-Reduces symptoms of 
endometriosis 
-Results in lighter, less 
frequent or absent menstrual 
bleeding 
-Improves dysmenorrhea  
(painful menses) 
-Prevents anemia 
Onset of 
Effectiveness 
Immediate Immediate 24 to 48 hours post-insertion 
Return to 
Fertility 
Immediate Immediate Immediate 
Discontinuation 
Rate (Year 1) 
8% to 26% 16% to 24% 
 
20% to 25% 
 
Top Reason for 
Discontinuation 
-Vaginal bleeding 
 
-Abdominal pain 
-Altered bleeding pattern 
 
-Abdominal pain 
-Irregular bleeding 
HIV/AIDS 
Medical 
Eligibility 
Criteria 
-Category 2 (recommended) 
for women with HIV 
 
-Category 3 (usually not 
recommended) for women 
with AIDS 
-Category 2 for women with 
HIV 
 
-Category 3 for women with 
AIDS 
 
-Category 1 (no restrictions) 
for women with HIV/AIDS 
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